MCID: STR008
MIFTS: 51

Strongyloidiasis

Categories: Gastrointestinal diseases, Infectious diseases, Neuronal diseases, Oral diseases, Rare diseases, Respiratory diseases, Skin diseases

Aliases & Classifications for Strongyloidiasis

MalaCards integrated aliases for Strongyloidiasis:

Name: Strongyloidiasis 12 74 52 58 54 3 43 15 17 71 32
Disseminated Strongyloidiasis 12 71 32
Anguilluliasis 58 71
Infection by Strongyloides 12
Threadworm Infection 52
Anguillulosis 58
Enterobiasis 71

Characteristics:

Orphanet epidemiological data:

58
strongyloidiasis
Inheritance: Not applicable; Age of onset: All ages;

Classifications:

Orphanet: 58  
Rare infectious diseases


External Ids:

Disease Ontology 12 DOID:10955
ICD9CM 34 127.2
MeSH 43 D013322
NCIt 49 C128398
SNOMED-CT 67 1214006
ICD10 32 B78 B78.7 B78.9
MESH via Orphanet 44 D013322
ICD10 via Orphanet 33 B78.0 B78.1 B78.7 more
UMLS via Orphanet 72 C0038463 C0085810
Orphanet 58 ORPHA76
UMLS 71 C0038463 C0085810 C0086227 more

Summaries for Strongyloidiasis

CDC : 3 Strongyloidiasis is a disease caused by a nematode, or a roundworm, in the genus Strongyloides. Though there are over 40 species within this genus that can infect birds, reptiles, amphibians, livestock and other primates, Strongyloides stercoralis is the primary species that accounts for human disease. It sometimes infects primates, dogs and cats, and some dog and primate infecting strains have been shown to be capable of causing human infection. We do not know if cat-infecting strains can infect humans or not. The larvae are small; the longest reach about 600 µm in length-making them very difficult to see with the naked eye.

MalaCards based summary : Strongyloidiasis, also known as disseminated strongyloidiasis, is related to meningitis and schistosomiasis, and has symptoms including fever and pruritus. An important gene associated with Strongyloidiasis is IL5 (Interleukin 5), and among its related pathways/superpathways are TGF-Beta Pathway and Cytokine Signaling in Immune system. The drugs Albendazole and Diethylcarbamazine have been mentioned in the context of this disorder. Affiliated tissues include testes, skin and t cells, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A parasitic helminthiasis infectious disease that involves infection of the intestine, lungs, skin and central nervous system with nematode Strongyloides stercoralis.

NIH Rare Diseases : 52 Strongyloidiasis is a parasitic disease caused by the roundworm Strongyloides stercoralis (S. stercoralis). People catch the infection when they come in contact with soil contaminated with the worms. While there are often no symptoms, abdominal pain, cough, diarrhea, rash, unintentional weight loss and vomiting may occur. The infection is treated with anti-worm medications such as ivermectin . Strongyloidiasis is found in tropical and subtropical areas, but can also be found in temperate regions, including the southern United States.

Wikipedia : 74 Strongyloidiasis is a human parasitic disease caused by the nematode called Strongyloides stercoralis,... more...

Related Diseases for Strongyloidiasis

Diseases related to Strongyloidiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 395, show less)
# Related Disease Score Top Affiliating Genes
1 meningitis 31.2 IL5 IL13 IFNG
2 schistosomiasis 30.9 IL5 IL13 IGHE IFNG
3 urticaria 30.9 IL5 IL13 IGHE
4 filariasis 30.7 LGALS3BP IL5 IGHE IFNG
5 hypereosinophilic syndrome 30.6 IL5 IL3 IL13 IGHE IFNG CCL11
6 toxocariasis 30.6 IL5 IGHE EPGN
7 diarrhea 30.5 TGFB1 IL5 IL3 IL13 IFNG
8 respiratory failure 30.4 IL5 IL13 IGHE CD4 CCL11
9 cystoisosporiasis 30.3 MT-CO1 CD4
10 lung disease 30.3 TGFB1 IL5 IL13 IFNG
11 t-cell lymphoblastic leukemia/lymphoma 30.3 IL5 IL3 CD7 CD4
12 trichuriasis 30.3 STH IL13 EPGN
13 norwegian scabies 30.2 IL5 CD4
14 allergic bronchopulmonary aspergillosis 30.2 IL5 IGHE IFNG
15 dermatitis 30.2 IL5 IL13 IGHE IFNG CCL11
16 necatoriasis 30.2 IL5 EPGN
17 intestinal tuberculosis 30.1 IFNG CD4
18 nocardiosis 30.1 IFNG CD4
19 giardiasis 30.1 TGFB1 STH CD79A CD4
20 bronchitis 30.1 IL5 IL13 IGHE CCL11
21 ancylostomiasis 30.1 MT-CO1 EPGN
22 drug allergy 30.1 IL5 IGHE CD4
23 leishmaniasis 30.1 TGFB1 IL5 IL13 IFNG
24 echinococcosis 30.1 MT-CO1 IL5 IGHE IFNG
25 immune deficiency disease 30.0 IL13 IFNG CD79A CD4
26 loiasis 30.0 STH IL5 IL13
27 bronchiolitis obliterans 30.0 TGFB1 IL13 IFNG
28 cryptococcosis 30.0 IL13 IFNG CD4
29 cryptosporidiosis 30.0 IFNG CD79A CD4 CCL11
30 ige responsiveness, atopic 30.0 IL5 IL13 IGHE IFNG
31 chagas disease 30.0 TGFB1 IFNG CD4
32 ascaris lumbricoides infection 29.9 STH IL5 IL13 IFNG EPGN
33 lung abscess 29.9 IFNG CD4
34 autoimmune disease 29.9 TGFB1 IL5 IL13 IFNG CD79A
35 pneumonia 29.9 IL5 IL13 IFNG CCL11
36 bronchiolitis 29.9 IL5 IL13 IFNG CCL11
37 pulmonary disease, chronic obstructive 29.9 TGFB1 IL5 IL13 CD4 CCL11
38 enterobiasis 29.9 STH MT-CO1 EPGN
39 toxoplasmosis 29.8 TGFB1 IL5 IFNG CD79A
40 folliculitis 29.8 IL5 IFNG CD4 CCL11
41 gastroenteritis 29.8 IL5 IL3 IFNG CCL11
42 cystic echinococcosis 29.7 MT-CO1 IGHE IFNG
43 pancytopenia 29.7 IL3 IFNG CD7 CD4
44 fascioliasis 29.7 MT-CO1 IFNG EPGN
45 conjunctivitis 29.7 IL5 IL13 IGHE IFNG CCL11
46 cysticercosis 29.6 STH MT-CO1 IGHE CD4
47 trichinosis 29.5 IL5 IL3 IL13 CD4
48 taeniasis 29.4 STH MT-CO1 CD4
49 t-cell adult acute lymphocytic leukemia 29.4 LTV1 HBZ CD7 CD4
50 inflammatory bowel disease 29.2 TGFB1 IL5 IL3 IL13 IFNG CCL11
51 onchocerciasis 29.2 STH LGALS3BP IL5 IL13 IGHE CCL11
52 parasitic protozoa infectious disease 29.1 MT-CO1 IL5 IL13 IFNG CD4
53 allergic hypersensitivity disease 28.7 IL5 IL3 IL13 IGHE IFNG CD4
54 filarial elephantiasis 28.7 STH MT-CO1 IL5 IL13 EPGN CD4
55 paragonimiasis 28.6 STH MT-CO1 IL5 IL13 IGHE EPGN
56 severe combined immunodeficiency 28.6 TGFB1 IL5 IL3 IL13 IFNG CD7
57 intestinal schistosomiasis 28.5 STH MT-CO1 IL5 IL13 EPGN CD4
58 asthma 28.4 TGFB1 IL5 IL3 IL13 IGHE IFNG
59 parasitic helminthiasis infectious disease 28.4 STH MT-CO1 IL5 IL3 IL13 EPGN
60 cytokine deficiency 10.5 IL5 IL13
61 immunoglobulin g deficiency 10.5 IGHE CD79A
62 exercise-induced anaphylaxis 10.5 IGHE CD79A
63 aztreonam allergy 10.5 IL5 IL13
64 eosinophilic fasciitis 10.5 IL5 IFNG
65 angioimmunoblastic lymphadenopathy with dysproteinemia 10.5 IL5 IL13
66 respiratory syncytial virus infectious disease 10.5 IL5 IL13
67 cefaclor allergy 10.5 IL5 IL13
68 staphylococcal toxic shock syndrome 10.5 IGHE IFNG
69 cefuroxime allergy 10.5 IL5 IL13
70 ocular toxoplasmosis 10.5 IGHE CD79A
71 ceftriaxone allergy 10.5 IL5 IL13
72 loeffler syndrome 10.5 IL5 IL13
73 ileus 10.4
74 anisakiasis 10.4 IGHE CD79A
75 nut allergy 10.4 IL5 IL13 IGHE
76 orofacial granulomatosis 10.4 IFNG CD79A
77 idiopathic nephrotic syndrome 10.4 TGFB1 IGHE
78 ocular tuberculosis 10.4 IFNG CD4
79 cough variant asthma 10.4 IL5 IL13 IGHE
80 schistosoma mansoni infection, susceptibility/ 10.4
81 leukemia, t-cell, chronic 10.4
82 bird fancier's lung 10.4 CD79A CD4
83 toxic oil syndrome 10.4 IL5 IGHE IFNG
84 cutaneous leishmaniasis 10.4 IL5 IL13 IFNG
85 panophthalmitis 10.4 IFNG CD4
86 latex allergy 10.4 IL5 IL13 IGHE
87 vernal conjunctivitis 10.4 IGHE IFNG
88 pericardial tuberculosis 10.4 IFNG CD4
89 purulent endophthalmitis 10.4 IFNG CD4
90 latent syphilis 10.4 IFNG CD4
91 stevens-johnson syndrome/toxic epidermal necrolysis 10.4 IL5 IL13 IFNG
92 exanthem 10.3
93 nephrotic syndrome 10.3
94 paralytic ileus 10.3
95 eosinophilic gastritis 10.3 IL5 IL13 CCL11
96 cerebral lymphoma 10.3 CD79A CD4
97 penicillin allergy 10.3 IL13 IGHE IFNG
98 penicilliosis 10.3 IFNG CD4
99 erythema multiforme 10.3 IL5 IL13 IFNG
100 posterior uveitis 10.3 IL5 IL13 IFNG
101 opportunistic bacterial infectious disease 10.3 IFNG CD4
102 adult t-cell leukemia 10.3
103 parapsoriasis 10.3 CD7 CD4
104 gastrointestinal tuberculosis 10.3 IFNG CD4
105 status asthmaticus 10.3 IL5 IL13 CCL11
106 pustulosis palmaris et plantaris 10.3 TGFB1 IL5 CD79A
107 dermatitis herpetiformis 10.3 IL5 CD79A CCL11
108 central nervous system tuberculosis 10.3 IFNG CD4
109 radiculopathy 10.3 IL5 IL13 CCL11
110 ostertagiasis 10.3 LGALS3BP EPGN
111 congenital syphilis 10.3 CD79A CD4
112 pulmonary eosinophilia 10.3 IL5 IL13 CCL11
113 chlamydia 10.3 IL5 IFNG CD79A
114 lymph node tuberculosis 10.3 IFNG CD4
115 follicular mucinosis 10.3 CD7 CD4
116 secondary syphilis 10.3 CD79A CD4
117 trichostrongyloidiasis 10.3 LGALS3BP EPGN
118 spongiotic dermatitis 10.3 CD7 CD4
119 eosinophilia-myalgia syndrome 10.3 TGFB1 IL5 IFNG
120 mikulicz disease 10.3 IL5 IL13 CD4
121 toxic shock syndrome 10.3
122 loeffler endocarditis 10.3 IL5 IL3
123 nickel allergic contact dermatitis 10.3 IL5 IFNG CD4
124 allergic contact dermatitis 10.3 IL5 IFNG CD4
125 contact dermatitis 10.3 IL5 IFNG CD4
126 pemphigoid gestationis 10.3 IL5 CCL11
127 legume allergy 10.3 IL5 IL13 CD4
128 fruit allergy 10.3 IL5 IL13 CD4
129 amoxicillin allergy 10.3 IL3 IGHE
130 chronic graft versus host disease 10.3 IFNG CD79A CD4
131 human immunodeficiency virus type 1 10.3
132 constipation 10.3
133 pemphigus 10.3
134 bacterial meningitis 10.3
135 chronic fatigue syndrome 10.3 IL5 IL13 IFNG
136 elephantiasis 10.3 STH IL5 IL13
137 sporotrichosis 10.3 IFNG CD79A CD4
138 immunodeficiency with hyper-igm, type 1 10.3 IGHE CD79A CD4
139 nonspecific interstitial pneumonia 10.3 TGFB1 IL13 IFNG
140 b-cell growth factor 10.3 IL3 IFNG
141 purpura 10.3
142 acquired immunodeficiency syndrome 10.3
143 chronic active epstein-barr virus infection 10.2 TGFB1 IFNG
144 abdominal tuberculosis 10.2 IFNG CD4
145 commensal bacterial infectious disease 10.2 IL5 IFNG CD4
146 hypereosinophilic syndrome, idiopathic 10.2 IL5 IL3
147 idiopathic interstitial pneumonia 10.2 TGFB1 IL13 IFNG
148 cellulitis 10.2 IL5 IFNG CD4
149 brucellosis 10.2 TGFB1 IL13 IFNG
150 syphilis 10.2 IFNG CD79A CD4
151 leprosy 3 10.2 IL5 IFNG CD4
152 ascaridiasis 10.2
153 lupus erythematosus 10.2
154 milk allergy 10.2 IL5 IL13 IGHE CD79A
155 farmer's lung 10.2 IGHE CD4
156 oral tuberculosis 10.2 IFNG CD4
157 pelvic inflammatory disease 10.2 IL13 IFNG CD4
158 peanut allergy 10.2 IL5 IL13 IGHE IFNG
159 pemphigus vegetans 10.2
160 systemic lupus erythematosus 10.2
161 adult respiratory distress syndrome 10.2
162 duodenitis 10.2
163 food allergy 10.2 IL5 IL13 IGHE IFNG
164 tuberculoid leprosy 10.2 TGFB1 IFNG CD4
165 vernal keratoconjunctivitis 10.2 IL5 IL13 IGHE CCL11
166 kimura disease 10.2 IL5 IL13 IGHE CCL11
167 tetanus 10.2 IL5 IL13 IFNG CD79A
168 bullous pemphigoid 10.2 IL5 IL13 IGHE CCL11
169 alcohol dependence 10.2
170 pemphigus vulgaris, familial 10.2
171 lymphoma 10.2
172 gnathomiasis 10.2 MT-CO1 LGALS3BP
173 chronic mucocutaneous candidiasis 10.2 IL5 IFNG CD4
174 proteasome-associated autoinflammatory syndrome 1 10.1 IL5 IL13 IFNG CCL11
175 egg allergy 10.1 IL5 IL13 IGHE CD4
176 dracunculiasis 10.1 STH EPGN
177 hyper ige syndrome 10.1 IL13 IGHE IFNG CCL11
178 multicentric castleman disease 10.1 IL5 IFNG CD79A CD4
179 colitis 10.1
180 duodenal ulcer 10.1
181 glomerulonephritis 10.1
182 peptic ulcer disease 10.1
183 vasculitis 10.1
184 human t-cell leukemia virus type 1 10.1
185 mucocutaneous leishmaniasis 10.1 IL5 IL13 IFNG CD4
186 disseminated eosinophilic collagen disease 10.1 IL5 IL3 CD7
187 eosinophilic gastroenteritis 10.1 IL5 IL3 CCL11
188 opportunistic mycosis 10.1 IL5 IL13 IFNG CD4
189 esophagitis 10.1 TGFB1 IL5 IL13 CCL11
190 fungal infectious disease 10.1 IL5 IL13 IFNG CD4
191 omenn syndrome 10.1 IL5 IGHE IFNG CD4
192 churg-strauss syndrome 10.1 IL5 IL3 CCL11
193 primary bacterial infectious disease 10.1 IL5 IL13 IFNG CD4
194 interstitial lung disease 10.1 TGFB1 IL5 IL13 IFNG
195 autoimmune disease of central nervous system 10.1 IL5 IL13 IFNG CD4
196 conjunctival disease 10.1 IL5 IL13 CD4 CCL11
197 common cold 10.1 IL5 IL13 CD4 CCL11
198 bone inflammation disease 10.1 IL13 IFNG CD4
199 integumentary system disease 10.1 IL5 IL13 IFNG CD4
200 scleral disease 10.1 IFNG CD4
201 bacterial infectious disease 10.1
202 protein-losing enteropathy 10.1
203 common variable immunodeficiency 10.1
204 leukemia 10.1
205 intestinal obstruction 10.1
206 gastroesophageal reflux 10.1 TGFB1 IL5 CCL11
207 intestinal pseudo-obstruction 10.1
208 alveolar echinococcosis 10.1
209 pericarditis 10.1
210 coccidiosis 10.1
211 distomatosis 10.1
212 behcet syndrome 10.1 IL5 IL13 IFNG CD4
213 upper respiratory tract disease 10.1 IL5 IL13 CD4 CCL11
214 myeloid and lymphoid neoplasms associated with fgfr1 abnormalities 10.1 IL3 CD4
215 sezary's disease 10.0 IL5 IFNG CD7 CD4
216 hymenolepiasis 10.0 STH MT-CO1
217 sarcoidosis 1 10.0 IL13 IFNG CD4 CCL11
218 intrinsic asthma 10.0 IL5 IL3 IL13 IGHE
219 leukemia, chronic lymphocytic 10.0
220 leukemia, acute lymphoblastic 10.0
221 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.0
222 membranoproliferative glomerulonephritis 10.0
223 pulmonary tuberculosis 10.0
224 duodenal obstruction 10.0
225 gastritis 10.0
226 peritonitis 10.0
227 bacterial pneumonia 10.0
228 amebiasis 10.0
229 47,xyy 10.0
230 pemphigus foliaceus 10.0
231 cytomegalovirus infection 10.0
232 diffuse alveolar hemorrhage 10.0
233 atopic keratoconjunctivitis 10.0 IL5 IL3 IGHE IFNG
234 pollen allergy 10.0 IL5 IL3 IL13 IGHE
235 allergic conjunctivitis 10.0 IL5 IL13 IGHE IFNG CCL11
236 mite infestation 10.0 MT-CO1 IL5 CD4
237 systemic scleroderma 10.0 TGFB1 IL13 IFNG CD4
238 rhinitis 10.0 IL5 IL13 IGHE IFNG CCL11
239 allergic rhinitis 10.0 IL5 IL13 IGHE IFNG CCL11
240 oesophagostomiasis 10.0 MT-CO1 EPGN
241 dacryoadenitis 10.0 IL13 CD4
242 esophagitis, eosinophilic, 1 10.0 IL5 IL3 IL13 CCL11
243 diphtheria 10.0 IL5 IL3 IL13 IFNG
244 polycystic echinococcosis 10.0 MT-CO1 LGALS3BP
245 eosinophilic pneumonia 10.0 IL5 IL3 IL13 CCL11
246 subcutaneous mycosis 10.0 IL3 CD4
247 primary biliary cirrhosis 9.9 IL5 IFNG CD79A CD4
248 chronic conjunctivitis 9.9 IL5 IL13 IGHE CD4 CCL11
249 volvulus of midgut 9.9
250 enterocolitis 9.9
251 lymphoma, hodgkin, classic 9.9
252 myeloma, multiple 9.9
253 lymphoma, non-hodgkin, familial 9.9
254 kala-azar 1 9.9
255 aspergillosis 9.9
256 acute diarrhea 9.9
257 cardiac arrest 9.9
258 hydrocephalus 9.9
259 uveitis 9.9
260 klebsiella pneumonia 9.9
261 candidiasis 9.9
262 angioedema 9.9
263 agammaglobulinemia 9.9
264 acute kidney failure 9.9
265 myelitis 9.9
266 pustulosis of palm and sole 9.9
267 kidney disease 9.9
268 reactive arthritis 9.9
269 scabies 9.9
270 ulcerative colitis 9.9
271 crohn's disease 9.9
272 psoriasis 9.9
273 48,xyyy 9.9
274 mollaret meningitis 9.9
275 polymyositis 9.9
276 angiostrongyliasis 9.9 MT-CO1 IL5 IL13 CCL11
277 eosinophilic meningitis 9.9 MT-CO1 IL5 IL13 CCL11
278 paranasal sinus disease 9.9 TGFB1 IL5 IL13 IFNG CD4
279 pulmonary fibrosis, idiopathic 9.8 TGFB1 IL5 IL13 IFNG CD4
280 eye disease 9.8 IL5 IL13 IFNG CD4 CCL11
281 hydronephrosis 9.8
282 otitis media 9.8 IL5 IL13 IGHE IFNG CD79A CCL11
283 parotitis 9.8 CD79A CD4
284 adult acute lymphocytic leukemia 9.8 HBZ CD7 CD4
285 keratoconjunctivitis 9.8 IL5 IL3 IL13 IFNG CCL11
286 bladder cancer 9.8
287 fibrosis of extraocular muscles, congenital, 1 9.8
288 myelopathy, htlv-1-associated 9.8
289 ovarian cancer 9.8
290 temporal arteritis 9.8
291 anemia, autoimmune hemolytic 9.8
292 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.8
293 thymoma, familial 9.8
294 gastrointestinal stromal tumor 9.8
295 mycobacterium tuberculosis 1 9.8
296 aplastic anemia 9.8
297 hepatitis c virus 9.8
298 mannose-binding lectin deficiency 9.8
299 bacteremia 1 9.8
300 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.8
301 diarrhea 9 9.8
302 bacterial sepsis 9.8
303 anaplastic large cell lymphoma 9.8
304 lymphoplasmacytic lymphoma 9.8
305 immunoglobulin alpha deficiency 9.8
306 ileocolitis 9.8
307 inguinal hernia 9.8
308 lymphoblastic lymphoma 9.8
309 endocarditis 9.8
310 microinvasive gastric cancer 9.8
311 meningoencephalitis 9.8
312 interstitial nephritis 9.8
313 gastric ulcer 9.8
314 dirofilariasis 9.8
315 microcytic anemia 9.8
316 portal vein thrombosis 9.8
317 pica disease 9.8
318 balantidiasis 9.8
319 acute leukemia 9.8
320 focal segmental glomerulosclerosis 9.8
321 acute cystitis 9.8
322 urethritis 9.8
323 opisthorchiasis 9.8
324 obstructive hydrocephalus 9.8
325 oral candidiasis 9.8
326 sclerosing cholangitis 9.8
327 viral hepatitis 9.8
328 enthesopathy 9.8
329 psychotic disorder 9.8
330 acute pancreatitis 9.8
331 iga glomerulonephritis 9.8
332 adenocarcinoma 9.8
333 glioblastoma multiforme 9.8
334 proctitis 9.8
335 tropical spastic paraparesis 9.8
336 thymoma 9.8
337 haemonchiasis 9.8
338 inappropriate adh syndrome 9.8
339 pulmonary fibrosis 9.8
340 arthropathy 9.8
341 liver disease 9.8
342 hyperglycemia 9.8
343 hypokalemia 9.8
344 rapidly progressive glomerulonephritis 9.8
345 pancreatitis 9.8
346 infertility 9.8
347 intestinal disease 9.8
348 t-cell acute lymphoblastic leukemia 9.8
349 hemolytic anemia 9.8
350 b-cell lymphoma 9.8
351 active peptic ulcer disease 9.8
352 chronic kidney disease 9.8
353 appendicitis 9.8
354 corneal ulcer 9.8
355 cholangitis 9.8
356 polyarteritis nodosa 9.8
357 cutaneous larva migrans 9.8
358 eosinophilic pustular folliculitis 9.8
359 glioma 9.8
360 htlv-1 associated myelopathy/tropical spastic paraparesis 9.8
361 lymphangiectasis 9.8
362 pemphigus and fogo selvagem 9.8
363 pustular psoriasis 9.8
364 spastic paraparesis 9.8
365 depression 9.8
366 back pain 9.8
367 chronic pain 9.8
368 dysphagia 9.8
369 encephalopathy 9.8
370 headache 9.8
371 posttransplant acute limbic encephalitis 9.8
372 glial tumor 9.8
373 secondary hemophagocytic lymphohistiocytosis 9.8
374 infective dermatitis associated with htlv-1 9.8
375 pemphigus erythematosus 9.8
376 glomerular disease 9.8
377 overgrowth syndrome 9.8
378 dermatitis, atopic 9.7 IL5 IL13 IGHE IFNG CD4 CCL11
379 diabetes mellitus, type i 9.7 IL5 IL13 IFNG CD79A CD4 CCL11
380 celiac disease 1 9.7 IL5 IL13 IFNG CD79A CD7 CD4
381 respiratory allergy 9.7 IL5 IL3 IL13 CD4 CCL11
382 multiple sclerosis 9.7 IL5 IL13 IFNG CD4 CCL11
383 leukocyte disease 9.7 IL5 IL3 IL13 CD4 CCL11
384 chronic meningitis 9.6 MT-CO1 IL5 IL13 CD4 CCL11
385 allergic asthma 9.6 IL5 IL3 IL13 IGHE IFNG CCL11
386 urinary schistosomiasis 9.6 STH IL5 IL13 IGHE IFNG EPGN
387 congenital myasthenic syndrome 9.5 TGFB1 STH MT-CO1 CD4
388 nasal cavity disease 9.5 IL5 IL3 IL13 IFNG CD4 CCL11
389 nose disease 9.5 IL5 IL3 IL13 IFNG CD4 CCL11
390 bronchial disease 9.5 IL5 IL3 IL13 IFNG CD4 CCL11
391 skin disease 9.5 IL5 IL13 IFNG CD79A CD7 CD4
392 diamond-blackfan anemia 9.5 TGFB1 RIOK2 LTV1 IL3
393 leukemia, acute myeloid 9.3 IL3 IFNG CD79A CD7 CD4
394 malaria 9.2 TGFB1 IL5 IL3 IL13 IFNG CD4
395 clonorchiasis 9.0 TGFB1 STH MT-CO1 IGHE IFNG EPGN

Graphical network of the top 20 diseases related to Strongyloidiasis:



Diseases related to Strongyloidiasis

Symptoms & Phenotypes for Strongyloidiasis

UMLS symptoms related to Strongyloidiasis:


fever, pruritus

MGI Mouse Phenotypes related to Strongyloidiasis:

45 (showing 2, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.65 CCL11 CD4 CD7 CD79A EPGN HBZ
2 immune system MP:0005387 9.36 CCL11 CD4 CD7 CD79A EPGN IFNG

Drugs & Therapeutics for Strongyloidiasis

Drugs for Strongyloidiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 17, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Albendazole Approved, Vet_approved Phase 3 54965-21-8 2082
2
Diethylcarbamazine Approved, Investigational, Vet_approved Phase 3 90-89-1 3052
3
Azithromycin Approved Phase 3 83905-01-5 447043 55185
4
Ivermectin Approved, Investigational, Vet_approved Phase 2, Phase 3 70288-86-7 6474909
5
Nitazoxanide Approved, Investigational, Vet_approved Phase 2, Phase 3 55981-09-4 41684
6 Antiprotozoal Agents Phase 3
7 Tubulin Modulators Phase 3
8 Antimitotic Agents Phase 3
9 Anti-Bacterial Agents Phase 3
10 Antiparasitic Agents Phase 2, Phase 3
11 Anti-Infective Agents Phase 2, Phase 3
12 Anthelmintics Phase 2
13 Milbemycin Phase 2
14
Formaldehyde Approved, Vet_approved 50-00-0 712
15
Mebendazole Approved, Vet_approved 31431-39-7 4030
16 Disinfectants
17 Ether

Interventional clinical trials:

(showing 14, show less)
# Name Status NCT ID Phase Drugs
1 Randomized, Open-label, Multi Centre Phase III Clinical Trial on Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis Completed NCT01570504 Phase 3 Ivermectin
2 Efficacy and Safety of Ivermectin Versus Albendazole for Chronic Strongyloidiasis Completed NCT00765024 Phase 3 Ivermectin;ivermectin;Albendazole
3 A Cluster Randomised Trial of the Safety of Co-Administration of IDA (Ivermectin, Diethylcarbamazine and Albendazole) & Azithromycin for Integrated Treatment of Neglected Tropical Diseases Completed NCT03676140 Phase 3 Albendazole on Day 1;Ivermectin on Day 1;Diethylcarbamazine on day 1;Azithromycin on Day 1;Azithromycin on Day 8
4 A Comparative Study of Two Regimens of Ivermectin for the Treatment of Strongyloides Stercoralis Infection Recruiting NCT03605758 Phase 3 Ivermectin
5 Clinical Trial Evaluating Safety and Efficacy of Ivermectin and Nitazoxanide Combination as Adjuvant Therapy in COVID-19 Newly Diagnosed Egyptian Patients: A Tanta University Hope Not yet recruiting NCT04360356 Phase 2, Phase 3
6 Efficacy, Safety and Pharmacokinetics of Ascending Dosages of Moxidectin Alone and in Comparison to Ivermectin Against Strongyloidiasis Stercoralis in Adults: a Randomized Controlled Trial Enrolling by invitation NCT04056325 Phase 2 Moxidectin;Ivermectin;Placebo oral tablet
7 Multicenter, Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy, Safety and Tolerability of Ivermectin in Mild Virus-positive Subjects (SARS-CoV)-2 With or Without Symptoms Not yet recruiting NCT04407507 Phase 2 Ivermectin;Placebo
8 Community-based Approach for the Management of Soil-transmitted Helminthiasis in General and Strongyloidiasis in Particular in a Highly Endemic Area Unknown status NCT01308268 Ivermectin + Albendazole
9 Study of Patients With Known or Suspected Infection With Strongyloides Stercoralis Completed NCT00001245
10 Host Response to Infection and Treatment in Lymphatic Filarial Disease Strongyloidiasis in India Completed NCT00342576
11 Diagnosis of Neglected Tropical Diseases (NTDs) in Patients Presenting With Persistent Digestive Disorders (≥2 Weeks) in Côte d'Ivoire, Indonesia, Mali and Nepal Completed NCT02105714
12 Efficacy and Nutritional Assessment Following Albendazole and Combined Albendazole/Ivermectin Treatment for Intestinal Helminth Infections in Rural Guatemalan Schoolchildren Completed NCT00207753 albendazole vs. combined albendazole/ivermectin treatment
13 The Sero-prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands Completed NCT01080989
14 Study of Patients With Parasitic Infections of the Gastrointestinal Tract Terminated NCT00001162

Search NIH Clinical Center for Strongyloidiasis

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Albendazole
Ivermectin
Mebendazole
Pyrantel
Pyrantel Pamoate
Thiabendazole

Cochrane evidence based reviews: strongyloidiasis

Genetic Tests for Strongyloidiasis

Anatomical Context for Strongyloidiasis

MalaCards organs/tissues related to Strongyloidiasis:

40
Testes, Skin, T Cells, Lung, Eye, Kidney, Small Intestine

Publications for Strongyloidiasis

Articles related to Strongyloidiasis:

(showing 1897, show less)
# Title Authors PMID Year
1
Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen. 61 54
19513105 2009
2
Eosinophil-selective mediators in human strongyloidiasis. 61 54
16879311 2006
3
The mutual influence of nematode infection and allergy. 61 54
16210900 2006
4
Strongyloides ratti antigenic components recognized by IgE antibodies in immunoblotting as an additional tool for improving the immunodiagnosis in human strongyloidiasis. 54 61
15057354 2004
5
Heterologous antigen extract in ELISA for the detection of human IgE anti-Strongyloides stercoralis. 61 54
14743666 2003
6
Immunoglobulin-E and anti-IgE treatment in lung disease. 54 61
11980283 2001
7
A three years follow-up of total serum IgE levels in three patients treated for strongyloidiasis. 61 54
11802274 2001
8
Influence of human T-cell lymphocytotropic virus type 1 infection on serologic and skin tests for strongyloidiasis. 61 54
11716123 2001
9
HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis. 54 61
11589779 2001
10
L3 antigen-specific antibody isotype responses in human strongyloidiasis: correlations with larval output. 61 54
10587378 1999
11
Differentially enhanced cytokine gene expression in CD4+ and CD8+ T cells in mesenteric lymph nodes in rats infected with Nippostrongylus brasiliensis. 54 61
10610496 1999
12
Interferon-gamma and interleukin-4 responses in relation to serum IgE levels in persons infected with human T lymphotropic virus type I and Strongyloides stercoralis. 54 61
9815251 1998
13
Humoral responses in human strongyloidiasis: correlations with infection chronicity. 54 61
9463683 1997
14
Total serum IgE and parasite-specific IgG and IgA antibodies in human strongyloidiasis. 54 61
8115797 1993
15
Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression. 61 54
1543206 1992
16
Regulatory T cell expansion resolves after effective strongyloidiasis treatment in subjects with HTLV-1 co-infection. 61
32120049 2020
17
Diagnostic update for an unusual case: recurrent strongyloidiasis. 61
30636686 2020
18
Strongyloides stercoralis hyperinfection syndrome presenting as mechanical ileus after short-course oral steroids for chronic obstructive pulmonary disease (COPD) exacerbation. 61
32087332 2020
19
The Global Prevalence of Strongyloides stercoralis Infection. 61
32545787 2020
20
Autochthonous Human and Canine Strongyloides stercoralis Infection in Europe: Report of a Human Case in An Italian Teen and Systematic Review of the Literature. 61
32503315 2020
21
Case Report: Incidentally Discovered Strongyloides stercoralis Infection after Urinary Diversion. 61
32228779 2020
22
Prevalence of Intestinal Parasites in a Low-Income Texas Community. 61
32207401 2020
23
Phylogenetic relationships of Strongyloides species in carnivore hosts. 61
32502520 2020
24
Serological assays for the diagnosis of Strongyloides stercoralis infection: a systematic review and meta-analysis of diagnostic test accuracy. 61
32052848 2020
25
A Case-Control Study on the Association Between Intestinal Helminth Infections and Treatment Failure in Patients With Cutaneous Leishmaniasis. 61
32494582 2020
26
Pictorial Review of Thoracic Parasitic Diseases: A Radiologic Guide. 61
31978430 2020
27
Performance of two serodiagnostic tests for loiasis in a Non-Endemic area. 61
32453734 2020
28
Hospitalization for Chagas disease, dengue, filariasis, leishmaniasis, schistosomiasis, strongyloidiasis, and Taenia solium taeniasis/cysticercosis, Italy, 2011-2016. 61
32418191 2020
29
Fatal Strongyloides stercoralis hyperinfection syndrome in an alcoholic diabetic patient from México 61
32463606 2020
30
Prevalence and risk factors of strongyloidiasis in patients with systemic lupus erythematosus in Southern Thailand. 61
32183590 2020
31
Should We Screen HIV-Positive Migrants for Strongyloidiasis? 61
32443596 2020
32
A Cross-Sectional Study of Seroprevalence of Strongyloidiasis in Pregnant Women (Peruvian Amazon Basin). 61
32375325 2020
33
Strongyloides stercoralis Hyper infection Syndrome. 61
32419745 2020
34
Strongyloides stercoralis seropositivity is not associated with increased symptoms in a remote Aboriginal community. 61
32372503 2020
35
Cost-effectiveness of different strategies for screening and treatment of Strongyloides stercoralis in migrants from endemic countries to the European Union. 61
32461226 2020
36
Genomic studies on Strongyloides stercoralis in northern and western Thailand. 61
32404172 2020
37
Integrating testing for chronic strongyloidiasis within the Indigenous adult preventive health assessment system in endemic communities in the Northern Territory, Australia: An intervention study. 61
32401755 2020
38
Update on the major imported helminth infections in travelers and migrants. 61
32250168 2020
39
Opportunistic tropical infections in immunosuppressed patients. 61
32299676 2020
40
The Strongyloides stercoralis-hookworms association as a path to the estimation of the global burden of strongyloidiasis: A systematic review. 61
32282827 2020
41
Transplant-related strongyloidiasis in solid organ transplant recipients in Saudi Arabia and the Gulf Cooperation Council countries. 61
31982623 2020
42
Parasitological and immunological aspects of oral and subcutaneous prednisolone treatment in rats experimentally infected with Strongyloides venezuelensis. 61
31958413 2020
43
Strongyloides Screening in Heart Transplant Candidates. 61
32465869 2020
44
Infection by Strongyloides stercoralis in immigrants with Chagas disease: evaluation of eosinophilia as screening method in primary care. 61
31845476 2020
45
Health of Special Immigrant Visa holders from Iraq and Afghanistan after arrival into the United States using Domestic Medical Examination data, 2014-2016: A cross-sectional analysis. 61
32231361 2020
46
[Recommendations for the screening for infectious diseases, mental health, and female genital mutilation in immigrant patients seen in Primary Care]. 61
31029458 2020
47
Imported Infections in Rural Mid-West United States - A Report from a Tertiary Care Center. 61
32308221 2020
48
Alcohol consumption alters anti-Strongyloides stercoralis antibodies production. 61
31902530 2020
49
Strongyloidiasis screening in migrants living in Spain: systematic review and meta-analysis. 61
31758828 2020
50
Development of immunochromatographic device as a point-of-care tool for serodiagnosis of human strongyloidiasis cases. 61
31758442 2020
51
Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975-2017. 61
32091375 2020
52
Improved agar plate culture conditions for diagnosis of Strongyloides stercoralis. 61
31816322 2020
53
Evaluation of the Dot-ELISA as a diagnostic test for human strongyloidiasis based on the detection of IgA in saliva. 61
31862463 2020
54
Strongyloides stercoralis Infection in Solid Organ Transplant Patients is Associated with Eosinophil Activation and Intestinal Inflammation: A Cross-sectional Study. 61
32155244 2020
55
High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study. 61
32053864 2020
56
Clinico-epidemiological spectrum of strongyloidiasis in India: Review of 166 cases. 61
32318369 2020
57
Rapid Progress toward Elimination of Strongyloidiasis in North Queensland, Tropical Australia, 2000-2018. 61
31802738 2020
58
Progress towards the Control of Strongyloidiasis in Tropical Australia? 61
31912774 2020
59
Overcoming challenges in the diagnosis and treatment of parasitic infectious diseases in migrants. 61
31914335 2020
60
Schistosomiasis, strongyloidiasis and Chagas disease: the leading imported neglected tropical diseases in Italy. 61
31840757 2020
61
Epidemiology of Parasitic Infections in the West Bank and Gaza Strip, Palestine. 61
31769396 2020
62
Ivermectin concentration in breastmilk of a woman with Strongyloides stercoralis and human T-lymphotropic virus-I co-infection. 61
31678122 2020
63
High Prevalence of Strongyloides among South Asian Migrants in Primary Care-Associations with Eosinophilia and Gastrointestinal Symptoms. 61
32041352 2020
64
Mapping the Prevalence of Strongyloides stercoralis Infection in Ecuador: A Serosurvey. 61
31833465 2020
65
[I promotori di salute come attori-protagonisti delle cure primarie nel controllo delle malattie comunicabili e non comunicabili e nell' empowerment delle comunità. Esperienza e risultati di lungo periodo in aree marginali in Ecuador dal 1980 al 2018.] 61
32458830 2020
66
Schistosoma and Strongyloides screening in migrants initiating HIV Care in Canada: a cross sectional study. 61
31992216 2020
67
Donor-derived fatal hyperinfection strongyloidiasis in renal transplant recipient. 61
32021802 2020
68
Strongyloides Hyperinfection Presenting as a Gastric Outlet Obstruction. 61
32064185 2020
69
Strongyloides hyperinfection in a patient with solid malignant tumor a case report. 61
32189692 2020
70
Strong-LAMP Assay Based on a Strongyloides spp.-Derived Partial Sequence in the 18S rRNA as Potential Biomarker for Strongyloidiasis Diagnosis in Human Urine Samples. 61
32566039 2020
71
Septic Meningitis and Liver Abscess due to Hypermucoviscous Klebsiella pneumoniae Complicated with Chronic Strongyloidiasis in a Human T-lymphotropic Virus 1 Carrier. 61
31434825 2020
72
Shotgun proteomics of Strongyloides venezuelensis infective third stage larvae: Insights into host-parasite interaction and novel targets for diagnostics. 61
31881239 2020
73
Strongyloides stercoralis: a rare and severe presentation in a pregnant woman. 61
31814031 2020
74
Strategies for management of strongyloidiasis in migrants from Sub-Saharan Africa recently arrived in Italy: A cost-effectiveness analysis. 61
31982632 2020
75
Coinfection of Strongyloides stercoralis and Aspergillus sp. 61
32565789 2020
76
HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases. 61
31648512 2019
77
Dogs are reservoir hosts for possible transmission of human strongyloidiasis in Thailand: molecular identification and genetic diversity of causative parasite species. 61
31843028 2019
78
Advances in the Molecular and Cellular Biology of Strongyloides spp. 61
31929961 2019
79
Assessment of the global paradigms of genetic variability in Strongyloides stercoralis infrapopulations determined by mitochondrial DNA sequences. 61
31586852 2019
80
Strongyloides stercoralis infection in human immunodeficiency virus-infected patients and related risk factors: A systematic review and meta-analysis. 61
31359566 2019
81
A single dose of ivermectin is sufficient for strongyloidiasis. 61
31558377 2019
82
Use of serology in a systematic screening programme for strongyloidiasis in an immigrant population. 61
31499208 2019
83
Strongyloidiasis in northern Vietnam: epidemiology, clinical characteristics and molecular diagnosis of the causal agent. 61
31685003 2019
84
Strongyloides stercoralis infection in a patient with rheumatoid arthritis and type 2 diabetes mellitus: a case-based review. 61
31123976 2019
85
Bacillus thuringiensis Cry5B is Active against Strongyloides stercoralis in vitro. 61
31516117 2019
86
Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase 3, randomised controlled superiority trial. 61
31558376 2019
87
Hepatobiliary strongyloidiasis presenting as an ampullary lesion on esophagogastroduodenoscopy/endoscopic ultrasound. 61
31687157 2019
88
Highly specific and sensitive anti-Strongyloides venezuelensis IgY antibodies applied to the human strongyloidiasis immunodiagnosis. 61
31128257 2019
89
A case of fatal disseminated strongyloidiasis accompanied with intestinal obstruction. 61
31772736 2019
90
Low prevalence of strongyloidiasis in Far North Queensland pregnant women. 61
31512300 2019
91
Microfilaria and Strongyloides larva diagnosed in cerebrospinal fluid and ascitic fluid, respectively: Approach to their morphology on cytology. 61
31211515 2019
92
From the feces to the genome: a guideline for the isolation and preservation of Strongyloides stercoralis in the field for genetic and genomic analysis of individual worms. 61
31640777 2019
93
Utility of PCR in Patients with Strongyloides stercoralis and HTLV-1 Coinfection in French Guiana. 61
31436152 2019
94
Prevalence and risk factors of Strongyloides stercoralis infection among Orang Asli schoolchildren: new insights into the epidemiology, transmission and diagnosis of strongyloidiasis in Malaysia. 61
31303180 2019
95
Disseminated strongyloidiasis complicated by alveolar hemorrhage, meningitis, and septic shock treated with albendazole and subcutaneous ivermectin. 61
31279610 2019
96
Parasitic infections in Malaysian aborigines with pulmonary tuberculosis: a comparative cross-sectional study. 61
31363922 2019
97
Parasitic Infections. 61
31507346 2019
98
Methotrexate exposure and risk of strongyloidiasis. 61
31302948 2019
99
A global genotyping survey of Strongyloides stercoralis and Strongyloides fuelleborni using deep amplicon sequencing. 61
31525192 2019
100
First molecular identification of Strongyloides fuelleborni in long-tailed macaques in Thailand and Lao People's Democratic Republic reveals considerable genetic diversity. 61
30027858 2019
101
Case Report: Two Cases of Strongyloidiasis Presenting with Thrombotic Events. 61
31218995 2019
102
Lateral Flow Dipstick Test for Serodiagnosis of Strongyloidiasis. 61
31218996 2019
103
Ivermectin: From theory to clinical application. 61
31071469 2019
104
Detection of classic and cryptic Strongyloides genotypes by deep amplicon sequencing: A preliminary survey of dog and human specimens collected from remote Australian communities. 61
31430282 2019
105
Strongyloides stercoralis Infection at Different Altitudes of the Cusco Region in Peru. 61
31264557 2019
106
Clinical and Diagnostic Features of 413 Patients Treated for Imported Strongyloidiasis at the Hospital for Tropical Diseases, London. 61
31219002 2019
107
Corticosteroid-induced immunodeficiency in a patient with gliomatosis cerebri: Are corticosteroids indicated in all brain tumors? 61
30964431 2019
108
Strongyloidiasis hyperinfection after renal transplant presenting as diffuse alveolar hemorrhage with respiratory failure. 61
31384205 2019
109
Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012-2017). 61
31363770 2019
110
Strongyloides stercoralis Hyperinfection and Concomitant Cytomegalovirus Gastroenteritis in an Immunocompromised Host. 61
31620532 2019
111
Soil-transmitted Helminths and Associated Risk Factors among Elementary School Pupils in Dadin Kowa, Jos. 61
31831936 2019
112
Strongyloidiasis in Ethiopia: systematic review on risk factors, diagnosis, prevalence and clinical outcomes. 61
31200770 2019
113
Disseminated Strongyloidiasis. 61
31188402 2019
114
HTLV-1-associated adult T-cell leukemia/lymphoma with disseminated strongyloidiasis. 61
31196878 2019
115
Strongyloides stercoralis in Patients on Corticosteroids Therapy Using Enzyme-Linked Immunosorbent Assay and Gelatin Particles Indirect Agglutination Tests: A Diagnostic Approach. 61
31069645 2019
116
Strongyloides Infection Presenting as Proximal Small Intestinal Obstruction. 61
31616778 2019
117
Serodiagnosis and early detection of Strongyloides stercoralis infection. 61
30482708 2019
118
Morbidity Associated with Chronic Strongyloides stercoralis Infection: A Systematic Review and Meta-Analysis. 61
30963990 2019
119
Strongyloides stercoralis hyperinfection syndrome: a deeper understanding of a neglected disease. 61
31263320 2019
120
Parasitic Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient, Including Toxoplasmosis and Strongyloidiasis. 61
31005139 2019
121
Production of recombinant 14-3-3 protein and determination of its immunogenicity for application in serodiagnosis of strongyloidiasis. 61
30856271 2019
122
[Screening the asymptomatic traveler returning from the tropics]. 61
31050236 2019
123
A case report suggestive of strongyloidiasis infection occurring in temperate Australia. 61
31084034 2019
124
Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017). 61
31095570 2019
125
Disseminated strongyloidiasis in an immunocompetent male: A Case Report. 61
31105313 2019
126
Comparison of ELISA and PCR of the 18S rRNA gene for detection of human strongyloidiasis using serum sample. 61
30773081 2019
127
Characterization of a non-sexual population of Strongyloides stercoralis with hybrid 18S rDNA haplotypes in Guangxi, Southern China. 61
31059500 2019
128
Disseminated Strongyloidiasis: Breaking Brain Barriers. 61
31007445 2019
129
Implementation of a Strongyloides screening strategy in solid organ transplant donors and recipients. 61
30773692 2019
130
In vitro anthelmintic activity of Siparuna guianensis extract and essential oil against Strongyloides venezuelensis. 61
30973122 2019
131
[Strongyloidiasis, a sexually transmitted disease]. 61
30853289 2019
132
Strongyloidiasis: A Neglected Tropical Disease. 61
30712758 2019
133
Donor-derived strongyloidiasis in a Saudi pediatric kidney transplant recipient: A case report and mini-review. 61
30578622 2019
134
Migration Medicine. 61
30712766 2019
135
Strongyloides stercoralis infection: A systematic review of endemic cases in Spain. 61
30860995 2019
136
Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis. 61
30683241 2019
137
Strongyloidiasis and schistosomiasis: lessons from migrants' data. 61
30683227 2019
138
Hemoptysis in the Immunocompromised Patient: Do Not Forget Strongyloidiasis. 61
30759812 2019
139
Donor-derived strongyloidiasis after organ transplantation in Norway. 61
30295406 2019
140
Lethal strongyloidiasis - Diagnostic and forensic issues. 61
30738288 2019
141
[Duodenal obstruction by Strongyloides stercoralis, an unusual complication]. 61
31095209 2019
142
IgG reactivity with 40-35 kDa soluble and membrane antigen of Strongyloides venezuelensis in immunocompromised patients. 61
30552879 2019
143
The investigation of Strongyloides stercoralis seroprevalence in immunosupressed patients in Turkey 61
30761833 2019
144
The Experimental Infections of the Human Isolate of Strongyloides Stercoralis in a Rodent Model (The Mongolian Gerbil, Meriones Unguiculatus). 61
30764580 2019
145
Efficacy of ivermectin to control Strongyloides stercoralis infection in sheltered dogs. 61
30465740 2019
146
Strongyloides venezuelensis infection augments arterial blood pressure in male wistar rats. 61
30529092 2019
147
A bibliometric analysis of human strongyloidiasis research (1968 to 2017). 61
31890240 2019
148
Case Report: Central Nervous System Strongyloidiasis: Two Cases Diagnosed Antemortem. 61
30457095 2019
149
Fatty acid and retinol-binding protein: A novel antigen for immunodiagnosis of human strongyloidiasis. 61
31329601 2019
150
[Strongyloides hyperinfection in patient from Patagonia with HTLV-1 co-infection]. 61
31048281 2019
151
Strongyloidiasis Presenting as Yellowish Nodules in Colonoscopy of an Immunocompetent Patient. 61
30157619 2019
152
Evaluation of the inhibitory effect of ivermectin on the growth of Babesia and Theileria parasites in vitro and in vivo. 61
31337949 2019
153
[About a Case of Febrile Gastroenteritis Due to Strongyloidiasis in a Gabonese Patient Treated for Lupus]. 61
31225731 2019
154
The Anthelmintic Effect on Strongyloides venezuelensis Induced by BnSP- 6, a Lys49-phospholipase A2 Homologue from Bothrops pauloensis Venom. 61
31340738 2019
155
Critical diagnosis of complicated strongyloidosis with nested-PCR and High Resolution Melting analysis (HRM) 61
32191823 2019
156
Sequential Changes in the Host Gut Microbiota During Infection With the Intestinal Parasitic Nematode Strongyloides venezuelensis. 61
31293983 2019
157
Influence of parasite load on the diagnosis and occurrence of eosinophilia in alcoholic patients infected with Strongyloides stercoralis. 61
29179791 2019
158
Epidemiology of Strongyloides stercoralis infection in Bolivian patients at high risk of complications. 61
30653489 2019
159
In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensis. 61
31778389 2019
160
Strongyloides infection as a reversible cause of chronic urticaria. 61
30881049 2019
161
Screening of Strongyloides infection using an ELISA test in transplant candidates. 61
31188909 2019
162
Strongyloides stercoralis infection in San Marino Republic: first epidemiological data from an observational study. 61
31364552 2019
163
Accuracy of Urine and Serum Assays for the Diagnosis of Strongyloidiasis by Three Enzyme-Linked Immunosorbent Assay Protocols. 61
30398144 2019
164
Implementation and evaluation of a quality and safety tool for ambulatory strongyloidiasis patients at high risk of adverse outcome. 61
30988956 2019
165
OCCASIONAL DIGESTIVE HEMORRHAGE IN CHILDREN DUE TO STRONGYLOIDIASIS: IMPORTANCE OF PARASITOLOGIC TESTING. 61
30066826 2019
166
Case Report: Strongyloides stercoralis Hyperinfection in a Patient with HTLV-1: An Infection with Filariform and Rhabditiform Larvae, Eggs, and Free-Living Adult Females Output. 61
30277207 2018
167
Effectiveness of Screening and Treatment Approaches for Schistosomiasis and Strongyloidiasis in Newly-Arrived Migrants from Endemic Countries in the EU/EEA: A Systematic Review. 61
30577567 2018
168
Disseminated Strongyloidiasis. 61
30665485 2018
169
Case Report: Subcutaneous Ivermectin Pharmacokinetics in Disseminated Strongyloides Infection: Plasma and Postmortem Analysis. 61
30334520 2018
170
Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review. 61
30353268 2018
171
Strongyloidiasis and Culture-Negative Suppurative Meningitis, Japan, 1993-2015. 61
30457540 2018
172
Enterobius vermicularis infection mimicking strongyloidiasis: A case report. 61
30190233 2018
173
A case of chronic strongyloidiasis diagnosed by histopathological study. 61
30261269 2018
174
Challenge in the diagnosis of pulmonary strongyloidiasis. 61
30569952 2018
175
Late post-kidney transplant Strongyloides hyperinfection syndrome. 61
30107075 2018
176
Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy. 61
30226142 2018
177
Seroepidemiological aspects of human infection by Strongyloides stercoralis in Alfenas, southern Minas Gerais, Brazil. 61
30517543 2018
178
High seroprevalence of Strongyloides stercoralis among individuals from endemic areas considered for solid organ transplant donation: A retrospective serum-bank based study. 61
30496174 2018
179
Detection of immune complexes and evaluation of alcoholic individuals' serological profile in the diagnosis of strongyloidiasis. 61
29933043 2018
180
Impact of the health education and preventive equipment package (HEPEP) on prevention of Strongyloides stercoralis infection among rural communities in Northeast Thailand: a cluster randomized controlled trial. 61
30340481 2018
181
[Severe infection by Strongyloides stercoralis in ascitic liquid]. 61
30860511 2018
182
Hypermetabolic Diffuse Proximal Small Bowel Wall Thickening on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography? Consider Strongyloidiasis among the Differentials. 61
30386068 2018
183
Inducible nitric oxide synthase controls experimental Strongyloides infection. 61
30035318 2018
184
Diagnostic comparison of Baermann funnel, Koga agar plate culture and polymerase chain reaction for detection of human Strongyloides stercoralis infection in Maluku, Indonesia. 61
30074085 2018
185
Fatal strongyloidiasis after corticosteroid therapy for presumed chronic obstructive pulmonary disease. 61
30425838 2018
186
Strongyloides stercoralis: detection of parasite-derived DNA in serum samples obtained from immunosuppressed patients. 61
29978421 2018
187
[Severe Strongyloides stercoralis infection: a case report]. 61
30350521 2018
188
Central nervous system Strongyloides stercoralis. A case report. 61
30649819 2018
189
Parasite allergens. 61
29588070 2018
190
Global output of research on epidermal parasitic skin diseases from 1967 to 2017. 61
30078380 2018
191
Is Ivermectin Ineffective for Strongyloidiasis? 61
29788131 2018
192
Pulmonary strongyloidiasis presenting micronodules on chest computed tomography. 61
30233896 2018
193
Molecular and Immnune Diagnosis: Further Testing for Human Strongyloidiasis. 61
29934882 2018
194
Human Strongyloidiasis in Hawaii: A Retrospective Review of Enzyme-Linked Immunosorbent Assay Serodiagnostic Testing. 61
29943712 2018
195
Molecular diagnosis of Strongyloides stercoralis among transplant candidates. 61
29679429 2018
196
Immune complex detection in saliva samples: an innovative proposal for the diagnosis of human strongyloidiasis. 61
29239289 2018
197
[A disseminated strongyloidiasis in a non immunocompromised patient]. 61
30113779 2018
198
Periumbilical purpura: dermatoscopic findings in disseminated strongyloidiasis. 61
29740812 2018
199
Evaluation of two prognostic indices for adult T-cell leukemia/lymphoma in the subtropical endemic area, Okinawa, Japan. 61
29772611 2018
200
Strongyloidiasis in humans: diagnostic efficacy of four conventional methods and real-time polymerase chain reaction. 61
30133633 2018
201
Worming Your Way Through the Gastrointestinal Tract: A Case of Strongyloidiasis. 61
29505750 2018
202
Current high prevalences of Strongyloides stercoralis and Opisthorchis viverrini infections in rural communities in northeast Thailand and associated risk factors. 61
30064407 2018
203
Paediatric Strongyloidiasis in Central Australia. 61
30274460 2018
204
Transrenal DNA-based diagnosis of Strongyloides stercoralis (Grassi, 1879) infection: Bayesian latent class modeling of test accuracy. 61
29856738 2018
205
Argument for Inclusion of Strongyloidiasis in the Australian National Notifiable Disease List. 61
30274457 2018
206
Metaperiodate deglycosylation of Strongyloides venezuelensis larvae: Immunochemical characterization and antigen production for human strongyloidiasis diagnosis. 61
29454735 2018
207
Organ donor screening practices for Strongyloides stercoralis infection among US organ procurement organizations. 61
29512242 2018
208
Concurrent Infection of a Young Tourist by Hookworm and Strongyloides Stercoralis During Low Budget Travel in Southeast Asia. 61
31662643 2018
209
Treatment of disseminated Strongyloides spp. infection in an infant Sumatran orangutan (Pongo abelii). 61
29493782 2018
210
Disseminated Strongyloidiasis in Association with Nephrotic Syndrome. 61
30197904 2018
211
Strongyloidiasis Outside Endemic Areas: Long-term Parasitological and Clinical Follow-up After Ivermectin Treatment. 61
29360939 2018
212
ELISA based on a recombinant Paragonimus heterotremus protein for serodiagnosis of human paragonimiasis in Thailand. 61
29843786 2018
213
Mansonella perstans, Onchocerca volvulus and Strongyloides stercoralis infections in rural populations in central and southern Togo. 61
29774301 2018
214
Parasitic Infections Associated with Unfavourable Outcomes in Transplant Recipients. 61
30344258 2018
215
A Community-Directed Integrated Strongyloides Control Program in Queensland, Australia. 61
30274444 2018
216
The Health Effects of Strongyloidiasis on Pregnant Women and Children: A Systematic Literature Review. 61
30274446 2018
217
The Unique Life Cycle of Strongyloides stercoralis and Implications for Public Health Action. 61
30274449 2018
218
Extended screening for infectious diseases among newly-arrived asylum seekers from Africa and Asia, Verona province, Italy, April 2014 to June 2015. 61
29692316 2018
219
Gastroduodenal involvement in disseminated strongyloidiasis. 61
30483566 2018
220
Identification and Preliminary Evaluation of a Novel Recombinant Protein for Serodiagnosis of Strongyloidiasis. 61
29436335 2018
221
Severe Strongyloidiasis in Solid Organ Transplant Recipients: Should We Preventively Treat the Recipient, the Donor, or Both? 61
29363441 2018
222
Terminal ileum resection as a trigger for Strongyloides stercoralis hyperinfection and ensuing serial sepsis in a 37-year-old patient with complicated Crohn's disease: a case report. 61
29642251 2018
223
Eosinophilia in Advanced HIV Infection with Hyperinfection Syndrome: A Case Report. 61
29962800 2018
224
Investigations for the Possible Use of a Monoclonal Antibody Produced against Strongyloides ratti Antigen as an Immunodiagnostic Reagent for Active Strongyloidiasis. 61
30069204 2018
225
Opportunistic and non-opportunistic intestinal parasites in HIV/ AIDS patients in relation to their clinical and epidemiological status in a specialized medical service in Goiás, Brazil. 61
29538510 2018
226
Recommendations for Management of Endemic Diseases and Travel Medicine in Solid-Organ Transplant Recipients and Donors: Latin America. 61
29381647 2018
227
Schistosomiasis and Strongyloidiasis Recommendations for Solid-Organ Transplant Recipients and Donors. 61
29381575 2018
228
Management of severe strongyloidiasis attended at reference centers in Spain. 61
29474356 2018
229
Image Gallery: Periumbilical purpura: a dermatological clue for disseminated strongyloidiasis. 61
29441550 2018
230
Electroacupuncture in rats infected with Strongyloides venezuelensis: effects on gastrointestinal transit and parasitological measurements. 61
29102965 2018
231
Fatal pancytopenia due to albendazole treatment for strongyloidiasis. 61
29942764 2018
232
Pulmonary strongyloidiasis causing septic shock in a patient with Crohn's disease. 61
29977759 2018
233
Low incidence of helminth infections (schistosomiasis, strongyloidiasis, filariasis, toxocariasis) among Dutch long-term travelers: A prospective study, 2008-2011. 61
29847574 2018
234
Coinfections between Persistent Parasitic Neglected Tropical Diseases and Viral Infections among Prisoners from Sub-Saharan Africa and Latin America. 61
30532789 2018
235
Newly Arrived African Migrants to Spain: Epidemiology and Burden of Disease. 61
29165212 2018
236
Strongyloides stercoralis infection in a Spanish regional hospital: Not just an imported disease. 61
27743682 2018
237
Chronic strongyloidiasis with recurrent asthma exacerbations and steroid-associated 'hives'. 61
29348277 2018
238
Chronic intestinal pseudo-obstruction due to Strongyloides stercoralis. 61
30101070 2018
239
Strongyloides stercoralis hyperinfection in an unconscious diabetic patient with dermatomyositis. 61
29567897 2018
240
Prevalence of and risk factors for malaria, filariasis, and intestinal parasites as single infections or co-infections in different settlements of Gabon, Central Africa. 61
29378644 2018
241
Prevalence and molecular characterization of Strongyloides stercoralis, Giardia duodenalis, Cryptosporidium spp., and Blastocystis spp. isolates in school children in Cubal, Western Angola. 61
29378626 2018
242
High prevalence of S. Stercoralis infection among patients with Chagas disease: A retrospective case-control study. 61
29385128 2018
243
Strongyloidosis Hyperinfection Syndrome in an HIV-Infected Patient: A Rare Manifestation of Immune Reconstitution Inflammatory Syndrome. 61
30510823 2018
244
Prevalence and associated risk factors of Strongyloides stercoralis infection in Lower Myanmar. 61
30598622 2018
245
Cross-Cultural, Aboriginal Language, Discovery Education for Health Literacy and Informed Consent in a Remote Aboriginal Community in the Northern Territory, Australia. 61
30274413 2018
246
Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis. 61
29985913 2018
247
Molecular diagnosis of strongyloidiasis in a population of an endemic area through nested-PCR. 61
29564068 2018
248
Parasitological versus molecular diagnosis of strongyloidiasis in serial stool samples: how many? 61
28112060 2018
249
A case of adenocarcinoma developed in the small intestine with chronic strongyloidiasis. 61
28988405 2017
250
Avidity as a criterion for diagnosis of human strongyloidiasis increases specificity of IgG ELISA. 61
28969935 2017
251
The severely under-recognized public health risk of strongyloidiasis in North American cities-A One Health approach. 61
28670749 2017
252
Anemia, intractable vomiting, chronic diarrhea, and syndrome of inappropriate antidiuretic secretion: a diagnostic dilemma: Disseminated strongyloidosis in a patient with newly diagnosed HTLV infection-case report and review of literature. 61
29384908 2017
253
Application of PCR-Based Tools to Explore Strongyloides Infection in People in Parts of Northern Australia. 61
30270919 2017
254
Case Report: A Case of Recurrent Strongyloides stercoralis Colitis in a Patient with Multiple Myeloma. 61
29140233 2017
255
Acute strongyloidiasis in a child recently returned from vacation in Cuba. 61
29158455 2017
256
Strongyloides stercoralis seroprevalence in Vietnam. 61
29039287 2017
257
Strongyloides stercoralis infection increases the likelihood to detect Trypanosoma cruzi DNA in peripheral blood in Chagas disease patients. 61
28869694 2017
258
Seroepidemiological trend of strongyloidiasis in the Bolivian Chaco (1987-2013) in the absence of disease-specific control measures. 61
28929562 2017
259
The changing aetiology of eosinophilia in migrants and returning travellers in the Hospital for Tropical Diseases, London 2002-2015: An observational study. 61
28842188 2017
260
Occlusive Nonvasculitic Vasculopathy. 61
27759698 2017
261
Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems. 61
28893741 2017
262
An eleven-year retrospective hospital-based study of epidemiological data regarding human strongyloidiasis in northeast Thailand. 61
28923008 2017
263
Evidence-Based Guidelines for Screening and Management of Strongyloidiasis in Non-Endemic Countries. 61
28749768 2017
264
Strongyloides stercoralis in solid organ transplantation: early diagnosis gets the worm. 61
28562417 2017
265
Purpuric lesion in an immunocompromised patient: a presentation of disseminated strongyloidiasis. 61
28261873 2017
266
Mass drug administration for the prevention human strongyloidiasis should consider concomitant treatment of dogs. 61
28837662 2017
267
Different but overlapping populations of Strongyloides stercoralis in dogs and humans-Dogs as a possible source for zoonotic strongyloidiasis. 61
28793306 2017
268
Occurrence of strongyloidiasis in privately owned and sheltered dogs: clinical presentation and treatment outcome. 61
28728589 2017
269
Viability of Strongyloides venezuelensis eggs and larvae in vermiculite containing the fungus Duddingtonia flagrans. 61
28508164 2017
270
Serological and molecular tests for the diagnosis of Strongyloides stercoralis infection in dogs. 61
28493000 2017
271
Spectrum and burden of neglected tropical diseases observed in an infectious and tropical diseases unit in Florence, Italy (2000-2015). 61
28054225 2017
272
Screening of immunocompromised patients at risk of strongyloidiasis in western Turkey using ELISA and real-time PCR. 61
28618740 2017
273
Identification of antigenic proteins in Strongyloides stercoralis by proteomic analysis. 61
28455628 2017
274
Novel Findings in HIV, Immune Reconstitution Disease and Strongyloides stercoralis Infection. 61
28641722 2017
275
Seroprevalence of five neglected parasitic diseases among immigrants accessing five infectious and tropical diseases units in Italy: a cross-sectional study. 61
28259548 2017
276
Pulmonary strongyloidiasis: assessment between manifestation and radiological findings in 16 severe strongyloidiasis cases. 61
28464844 2017
277
Disseminated strongyloidiasis and concomitant Aspergillus infection with central nervous system involvement. 61
28139968 2017
278
Cross-reactivity of the 31 kDa antigen of Angiostrongylus cantonensis - Dealing with the immunodiagnosis of meningoencephalitis. 61
27866477 2017
279
[Duodenal Linphoma asociated to Strongyloides stercoralis infection. Two types of HTLV-1 infection]. 61
28731999 2017
280
Diagnosis of Strongyloides stercoralis by morphological characteristics combine with molecular biological methods. 61
28124134 2017
281
In vitro efficacy of latex and purified papain from Carica papaya against Strongyloides venezuelensis eggs and larvae. 61
28380118 2017
282
Strongyloidiasis in Latin American immigrants: a pilot study. 61
27121364 2017
283
Intestinal strongyloidiasis: radiological findings that support the diagnosis. 61
28428660 2017
284
Strongyloides infection in rodents: immune response and immune regulation. 61
26905057 2017
285
A Strong and Fortuitous Case of Dyspnea. 61
28414672 2017
286
Enterococcal meningitis in association with Strongyloides hyperinfection syndrome. 61
28331839 2017
287
[Clinical and epidemiological characteristics of strongyloidiasis in patients with comorbidities]. 61
28394981 2017
288
Unexpected hosts: imaging parasitic diseases. 61
27882478 2017
289
Strongyloides hyperinfection following hematopoietic stem cell transplant in a patient with HTLV-1-associated T-cell leukemia. 61
27860061 2017
290
Gastric Strongyloidiasis: Report of 2 Cases and Brief Review of the Literature. 61
27965275 2017
291
Potential immunological markers for diagnosis of human strongyloidiasis using heterologous antigens. 61
27894367 2017
292
The impact of prenatal exposure to parasitic infections and to anthelminthic treatment on antibody responses to routine immunisations given in infancy: Secondary analysis of a randomised controlled trial. 61
28178298 2017
293
Strongyloidiasis Current Status with Emphasis in Diagnosis and Drug Research. 61
28210503 2017
294
Colorectal Cancer Associated with Strongyloides stercoralis Colitis. 61
28879209 2017
295
Screening for parasite infections in immigrant children from low-income countries. 61
27156246 2017
296
Twenty-five Years of Chronic Strongyloidiasis in an Immigrant. 61
28469498 2017
297
Case report of a computerized tomography sign in Strongyloides stercoralis infection. 61
28721104 2017
298
A Case of Bacteremia and Meningitis Associated with Piperacillin-Tazobactam Nonsusceptible, Ceftriaxone Susceptible Escherichia coli during Strongyloides Hyperinfection in an Immunocompromised Host. 61
29359054 2017
299
Biliary Strongyloides stercoralis With Cholecystitis and Extensive Portal Vein Thrombosis. 61
29181423 2017
300
A Case of Strongyloidiasis: An Immigrant Healthcare Worker Presenting with Fatigue and Weight Loss. 61
28744381 2017
301
Linear and urticarial rash-like manifestation of acute strongyloidiasis. 61
27613704 2017
302
[Strongyloidiasis native to Asturias]. 61
27151772 2017
303
Strongyloidiasis-Related IRIS. 61
27733639 2017
304
Surveillance of strongyloidiasis in Spanish in-patients (1998-2014). 61
29284005 2017
305
Importance of a Rapid and Accurate Diagnosis in Strongyloides Stercoralis and Human T-Lymphotropic Virus 1 Co-infection: A Case Report and Review of the Literature. 61
29270152 2017
306
Th2/1 Hybrid Cells Occurring in Murine and Human Strongyloidiasis Share Effector Functions of Th1 Cells. 61
28676845 2017
307
Strongyloidiasis Presenting as Epigastric Pain. 61
27924100 2016
308
The Lack of Association of Eosinophilia and Neurocysticercosis at Clinical Presentation: A Retrospective Analysis of Cases Seen at the National Institutes of Health, 1985-2015. 61
27928090 2016
309
Strongyloides hyper infection in a steroid dependent leprosy patient. 61
30226358 2016
310
LIMIT OF MOLECULAR DETECTION OF STRONGYLOIDES STERCORALIS PARASITE PERFORMING.TWO PCR PROTOCOLS. 61
30230751 2016
311
Severe Anemia and Lung Nodule in an Immunocompetent Adopted Girl with Strongyloides stercoralis Infection. 61
27601521 2016
312
Pulmonary strongyloidiasis and hyperinfection in a renal transplant patient. 61
27891008 2016
313
Strongyloidiasis in Ontario: Performance of diagnostic tests over a 14-month period. 61
27794473 2016
314
[Strongyloidiasis as cause of lower gastrointestinal bleeding]. 61
28112346 2016
315
Pulmonary Strongyloidiasis Masquerading as Exacerbation of Chronic Obstructive Pulmonary Disease. 61
27790284 2016
316
Persistent infectious and tropical diseases in immigrant correctional populations. 61
27637104 2016
317
Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment. 61
27527631 2016
318
Characterization of patients with aggressive adult T-cell leukemia-lymphoma in Okinawa, Japan: a retrospective analysis of a large cohort. 61
27329124 2016
319
Effect of ivermectin on allergy-type manifestations in occult strongyloidiasis. 61
27566864 2016
320
[Pulmonary strongyloidiasis]. 61
28112345 2016
321
Strongyloides stercoralis diagnostic polypeptides for human strongyloidiasis and their proteomic analysis. 61
27312043 2016
322
Epidemiological Characteristics of Strongyloidiasis in Inhabitants of Indigenous Communities in Borneo Island, Malaysia. 61
27853126 2016
323
Donor-derived Strongyloides stercoralis hyperinfection syndrome after simultaneous kidney/pancreas transplantation. 61
27590562 2016
324
The alkylphospholipid edelfosine shows activity against Strongyloides venezuelensis and induces apoptosis-like cell death. 61
27394030 2016
325
Prevalence of Strongyloides stercoralis and Other Intestinal Parasites among Institutionalized Mentally Disabled Individuals in Rasht, Northern Iran. 61
28127364 2016
326
The prevalence and clinical associations of HTLV-1 infection in a remote Indigenous community. 61
27681971 2016
327
Acute strongyloidiasis in a traveller returning from South East Asia. 61
27192701 2016
328
Seroprevalence of fascioliasis, toxocariasis, strongyloidiasis and cysticercosis in blood samples diagnosed in Medic Medical Center Laboratory, Ho Chi Minh City, Vietnam in 2012. 61
27595647 2016
329
Seroepidemiology of Strongyloides stercoralis amongst immunocompromised patients in Southwest Iran. 61
29988178 2016
330
DIAGNOSIS OF Strongyloides stercoralis INFECTION IN IMMUNOCOMPROMISED PATIENTS BY SEROLOGICAL AND MOLECULAR METHODS. 61
27680168 2016
331
Advocating for both Environmental and Clinical Approaches to Control Human Strongyloidiasis. 61
27706031 2016
332
Donor-Derived Strongyloidiasis Infection in Solid Organ Transplant Recipients: A Review and Pooled Analysis. 61
27742318 2016
333
StrongNet: An International Network to Improve Diagnostics and Access to Treatment for Strongyloidiasis Control. 61
27607192 2016
334
IBD or strongyloidiasis? 61
26634698 2016
335
Parasites. 61
27726821 2016
336
Comparative Diagnosis of Strongyloidiasis in Immunocompromised Patients. 61
27296387 2016
337
Poorly controlled asthma and strongyloidiasis in a nonendemic area of the United States. 61
27298264 2016
338
Epidemiology of Strongyloides stercoralis in northern Italy: results of a multicentre case-control study, February 2013 to July 2014. 61
27525375 2016
339
First molecular identification and report of genetic diversity of Strongyloides stercoralis, a current major soil-transmitted helminth in humans from Lao People's Democratic Republic. 61
27083185 2016
340
Serodiagnosis of fasciolosis by fast protein liquid chromatography-fractionated excretory/secretory antigens. 61
27130320 2016
341
The role of IL-33/ST2, IL-4, and eosinophils on the airway hyperresponsiveness induced by Strongyloides venezuelensis in BALB/c mice. 61
27102638 2016
342
Economic Analysis of the Impact of Overseas and Domestic Treatment and Screening Options for Intestinal Helminth Infection among US-Bound Refugees from Asia. 61
27509077 2016
343
Disseminated Strongyloidiasis in an Immunodeficient Patient (Pemphigus Vulgaris) Due to Corticosteroid Therapy: A Case Report. 61
28127349 2016
344
Strongyloides stercoralis infection in patients with systemic lupus erythematosus: diagnosis and prevention of severe strongyloidiasis. 61
26258603 2016
345
Cutaneous Strongyloides Infection Postchemotherapy. 61
26896181 2016
346
Diagnosis of the strongyloid nematode Strongyloides venezuelensis in experimentally infected rats. 61
26169305 2016
347
Strong-LAMP: A LAMP Assay for Strongyloides spp. Detection in Stool and Urine Samples. Towards the Diagnosis of Human Strongyloidiasis Starting from a Rodent Model. 61
27415764 2016
348
Notes from the Field: Strongyloidiasis at a Long-Term-Care Facility for the Developmentally Disabled - Arizona, 2015. 61
27310213 2016
349
Comparison between the effect of Lawsonia inermis and flubendazole on Strongyloides species using scanning electron microscopy. 61
27413314 2016
350
In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis. 61
27353595 2016
351
Higher HTLV-1c proviral loads are associated with blood stream infections in an Indigenous Australian population. 61
27011343 2016
352
Incidence rate and risk factors for giardiasis and strongyloidiasis in returning UK travellers. 61
27432907 2016
353
Strongyloidiasis: A Disease of Socioeconomic Disadvantage. 61
27213420 2016
354
Specific IgG and immune complex responses to parthenogenetic females and eggs of nematode Strongyloides venezuelensis for the diagnosis of immunosuppression in infected rats. 61
25997825 2016
355
Comparison between PCR and larvae visualization methods for diagnosis of Strongyloides stercoralis out of endemic area: A proposed algorithm. 61
26868702 2016
356
A Fatal Strongyloides Stercoralis Hyperinfection Syndrome in a Patient With Chronic kidney Disease: A Case Report and Literature Review. 61
27175679 2016
357
Short epitope-based synthetic peptides for serodiagnosis of human strongyloidiasis. 61
26956434 2016
358
[Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use]. 61
26654554 2016
359
Disseminated Strongyloidiasis in an Iranian Immunocompromised Patient: A Case Report. 61
28096866 2016
360
Infectious Diseases in Sub-Saharan Immigrants to Spain. 61
26880782 2016
361
Real-Time Polymerase Chain Reaction in Stool Detects Transmission of Strongyloides stercoralis from an Infected Donor to Solid Organ Transplant Recipients. 61
26880781 2016
362
Impact of Helminth Infection on the Clinical and Microbiological Presentation of Chagas Diseases in Chronically Infected Patients. 61
27115603 2016
363
Chronic spontaneous urticaria and internal parasites--a systematic review. 61
26648083 2016
364
Unsuspected Strongyloides stercoralis infection in hospital patients with comorbidity in need of proper management. 61
26923091 2016
365
Severe strongyloidiasis in AIDS: relative risk obscured by absolute rarity. 61
26825034 2016
366
Association between Strongyloides stercoralis infection and cortisol secretion in alcoholic patients. 61
26592319 2016
367
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. 61
26778150 2016
368
Protein Loosing Enteropathy Secondary to Strongyloidiasis: Case Report and Review of the Literature. 61
26881152 2016
369
Strongyloides stercoralis Infection in Alcoholic Patients. 61
28105424 2016
370
Parasitic Infections in Hematopoietic Stem Cell Transplantation. 61
27413527 2016
371
Strongyloidiasis in a young French woman raises concern about possible ongoing autochthonous transmission in Spain. 61
26617257 2016
372
Chronic strongyloidiasis - Don't look and you won't find. 61
27051986 2016
373
Strongyloidiasis in the immunocompetent: an overlooked infection. 61
27609726 2016
374
CATMAT statement on disseminated strongyloidiasis: Prevention, assessment and management guidelines. 61
29769976 2016
375
Strongyloides Hyperinfection Syndrome Combined with Cytomegalovirus Infection. 61
27703835 2016
376
Subcutaneous ivermectin use in the treatment of severe Strongyloides stercoralis infection: two case reports and a discussion of the literature. 61
26462990 2016
377
Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States. 61
26925367 2016
378
Strongyloidiasis in immigrants and refugees in Canada. 61
26149698 2015
379
Mucocutaneous manifestations of helminth infections: Nematodes. 61
26568337 2015
380
Mucocutaneous manifestations of helminth infections: Trematodes and cestodes. 61
26568338 2015
381
Treatment with nitric oxide donors diminishes hyperinfection by Strongyloides venezuelensis in mice treated with dexamethasone. 61
26342794 2015
382
Comparison of parasitological, immunological and molecular methods for evaluation of fecal samples of immunosuppressed rats experimentally infected with Strongyloides venezuelensis. 61
26442899 2015
383
Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador. 61
26540412 2015
384
Clinical Image In Gastroenterology: Disseminated gastrointestinal strongyloidiasis. 61
26481977 2015
385
[A LOCAL CASE OF CHRONIC STRONGYLOIDIASIS IN THE VOLGOGRAD REGION]. 61
26827587 2015
386
Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome. 61
24902477 2015
387
Immunoblotting using Strongyloides venezuelensis larvae, parthenogenetic females or eggs extracts for the diagnosis of experimentally infected immunosuppressed rats. 61
26219202 2015
388
Detection of parasite-specific IgG and IgA in paired serum and saliva samples for diagnosis of human strongyloidiasis in northern Paraná state, Brazil. 61
26238982 2015
389
IMMUNODIAGNOSIS OF HUMAN STRONGYLOIDIASIS: USE OF SIX DIFFERENT ANTIGENIC FRACTIONS FROM Strongyloides venezuelensis PARASITIC FEMALES. 61
26603231 2015
390
Strongyloides stercoralis hyperinfection causing eosinophilic ascites. 61
26097138 2015
391
Parasite Antigen-Specific Regulation of Th1, Th2, and Th17 Responses in Strongyloides stercoralis Infection. 61
26202988 2015
392
Immunofluorescence assay for diagnosis of strongyloidiasis in immunocompromised patients. 61
25832456 2015
393
Infectious Risks of Traveling Abroad. 61
26350325 2015
394
Strongyloides stercoralis hyperinfection: an unusual cause of gastrointestinal bleeding. 61
26466210 2015
395
High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease. 61
26143070 2015
396
Chronic Larva Currens Following Tourist Travel to the Gambia and Southeast Asia Over 20 Years Ago. 61
25775620 2015
397
Cervical strongyloidiasis in an immunocompetent patient: A clinical surprise. 61
26275275 2015
398
A Fatal Case of Strongyloidiasis in Pregnancy. 61
25774935 2015
399
Serological study of Trypanosoma cruzi, Strongyloides stercoralis, HIV, human T cell lymphotropic virus (HTLV) and syphilis infections in asymptomatic Latin-American immigrants in Spain. 61
26065661 2015
400
Uncommon presentation of Strongyloidiasis: chronic malabsorption, multiple small bowel strictures and appendicitis in HTLV-1 positive patient. 61
27522750 2015
401
Comparative evaluation of Strongyloides ratti and S. stercoralis larval antigen for diagnosis of strongyloidiasis in an endemic area of opisthorchiasis. 61
25877389 2015
402
Strongyloidiasis: a case for notification in Australia? 61
26021359 2015
403
Persistent strongyloidiasis complicated by recurrent meningitis in an HTLV seropositive Peruvian migrant resettled in Italy. 61
25846292 2015
404
Parasitic colitis. 61
26034403 2015
405
Novel approaches to the diagnosis of Strongyloides stercoralis infection. 61
25887711 2015
406
Clinical conditions associated with intestinal strongyloidiasis in Rio de Janeiro, Brazil. 61
26108011 2015
407
Donor-derived Strongyloides stercoralis infection in solid organ transplant recipients in the United States, 2009-2013. 61
25703251 2015
408
Structural and functional characterization of a novel scFv anti-HSP60 of Strongyloides sp. 61
25994608 2015
409
Development of Ss-NIE-1 recombinant antigen based assays for immunodiagnosis of strongyloidiasis. 61
25860665 2015
410
[Strongyloidiasis: who is at risk of severe infection and how to prevent it?]. 61
26050304 2015
411
Strongyloidiasis with emphasis on human infections and its different clinical forms. 61
25911368 2015
412
Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy. 61
25925183 2015
413
Molecular diagnosis of strongyloidiasis in tropical areas: a comparison of conventional and real-time polymerase chain reaction with parasitological methods. 61
25946255 2015
414
Strongyloidiasis: an unusual cause of septic shock with pneumonia and enteropathy in western countries. 61
25819827 2015
415
[Strongyloidiasis in nephrologic patients]. 61
26005937 2015
416
Strongyloidiasis: a case with acute pancreatitis and a literature review. 61
25805946 2015
417
Five cases of recurrent meningitis associated with chronic strongyloidiasis. 61
25548379 2015
418
Bacteroides-associated pylephlebitis in a patient with strongyloidiasis. 61
25510718 2015
419
Is strongyloidiasis endemic in Spain? 61
25654324 2015
420
Prevalence of strongyloidiasis in Latin America: a systematic review of the literature. 61
24990510 2015
421
Strongyloidiasis in a healthy 8-year-old girl in north-eastern USA. 61
25022873 2015
422
Severe strongyloidiasis with negative serology after corticosteroid treatment. 61
25690926 2015
423
Application of real-time PCR for the detection of Strongyloides spp. in clinical samples in a reference center in Spain. 61
25447829 2015
424
Comorbid gastric adenocarcinoma and gastric and duodenal Strongyloides stercoralis infection: a case report. 61
25748714 2015
425
Accuracy of five serologic tests for the follow up of Strongyloides stercoralis infection. 61
25668740 2015
426
African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases. 61
26401658 2015
427
Screening for Schistosoma mansoni and Strongyloides stercoralis Infection Among Brazilian Immigrants in the United States. 61
26034754 2015
428
A COMPLICATED CASE OF STRONGYLOIDIASIS PRESENTING WITH INTESTINAL LYMPHADENOPATHY OBSTRUCTION: MOLECULAR IDENTIFICATION. 61
26513898 2015
429
Pulmonary Hemorrhage Secondary to Disseminated Strongyloidiasis in a Patient with Systemic Lupus Erythematosus. 61
26101672 2015
430
Gastrointestinal strongyloidiasis. 61
26062140 2015
431
Membrane fractions from Strongyloides venezuelensis in the immunodiagnosis of human strongyloidiasis. 61
25651330 2015
432
Megaduodenum associated with gastric strongyloidiasis. 61
25951613 2015
433
Strongyloidiasis in immigrants in Southern Spain. 61
25205127 2015
434
Disseminated strongyloidiasis in a patient with membranoproliferative glomerulonephritis-case report. 61
25904959 2015
435
Parasitic infections in travelers and immigrants: part II helminths and ectoparasites. 61
25598339 2015
436
[Weight loss and chronic diarrhea in a 54-year-old man with HIV infection]. 61
25583311 2015
437
Enterobiasis and strongyloidiasis and associated co-infections and morbidity markers in infants, preschool- and school-aged children from rural coastal Tanzania: a cross-sectional study. 61
25486986 2014
438
The detergent fraction is effective in the detection of IgG anti-Strongyloides stercoralis in serum samples from immunocompromised individuals. 61
25091831 2014
439
Management of Strongyloides stercoralis: a puzzling parasite. 61
25173343 2014
440
Strongyloides stercoralis infection in marmosets: replication of complicated and uncomplicated human disease and parasite biology. 61
25499310 2014
441
Strongyloides stercoralis and relatives: recent advances in general and molecular biology. 61
29577012 2014
442
[Fatal strongyloidiasis following corticosteroid therapy]. 61
25065661 2014
443
Gastroscopic findings of Strongyloidiasis causing unresolved upper gastrointestinal bleeding. 61
26349175 2014
444
Strongyloidiasis hyperinfection in a patient with a history of systemic lupus erythematosus. 61
25092815 2014
445
Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIE. 61
25051188 2014
446
[Diagnosis of Strongyloides Stercoralis infection: meta-analysis on evaluation of conventional parasitological methods (1980-2013)]. 61
25327268 2014
447
A patient with disseminated strongyloidiasis with erythroderma in a nonendemic area. 61
24720636 2014
448
Strongyloides stercoralis: systematic review of barriers to controlling strongyloidiasis for Australian indigenous communities. 61
25254655 2014
449
Strongyloidiasis--an insight into its global prevalence and management. 61
25121962 2014
450
Hyperinfection strongyloidiasis in renal transplant recipients. 61
25150235 2014
451
Development of a rapid serological assay for the diagnosis of strongyloidiasis using a novel diffraction-based biosensor technology. 61
25102174 2014
452
Strongyloides stercoralis infection in allogeneic stem cell transplant: a case report and review of the literature. 61
24890466 2014
453
Relevance of eosinophilia and hyper-IgE in immigrant children. 61
25058145 2014
454
A case report of strongyloidiasis associated with giardiasis in a patient with renal calculi from a tertiary care center in South India. 61
25191059 2014
455
Pulmonary strongyloidiasis following renal transplantation without travel to an endemic area. 61
25988037 2014
456
Update on immunologic and molecular diagnosis of human strongyloidiasis. 61
24686097 2014
457
Detection of Strongyloides stercoralis infection among cancer patients in a major hospital in Kelantan, Malaysia. 61
25091885 2014
458
[Intestinal strongyloidiasis in a psoriasis patient with diabetes]. 61
25016122 2014
459
High prevalence and spatial distribution of Strongyloides stercoralis in rural Cambodia. 61
24921627 2014
460
An unsuspected cause of diarrhoea and gastrointestinal bleeding during corticosteroid therapy. 61
25090826 2014
461
Usefulness of Strongyloides stercoralis serology in the management of patients with eosinophilia. 61
24615124 2014
462
Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature. 61
24612907 2014
463
Aetiologies of creeping eruption: 78 cases. 61
24116380 2014
464
Comparison of three immunoassays for detection of antibodies to Strongyloides stercoralis. 61
24648484 2014
465
Conventional PCR for molecular diagnosis of human strongyloidiasis. 61
24476900 2014
466
Regional variation in travel-related illness acquired in Africa, March 1997-May 2011. 61
24655358 2014
467
[Persistent tropical diseases among migrants]. 61
24791430 2014
468
A review of mortality from parasitic and vector-borne diseases in the U.S. Air Force from 1970 to 2012. 61
24224859 2014
469
Parasitic infections based on 320 clinical samples submitted to Hanyang University, Korea (2004-2011). 61
24850969 2014
470
Prevalence and risk factors of acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in Thailand. 61
24766337 2014
471
An Analysis of Clinical Characteristics of Strongyloides stercoralis in 70 indigenous patients in Iran. 61
25848380 2014
472
Global progress towards eliminating gastrointestinal helminth infections. 61
24241244 2014
473
Enteric infections. 61
24706227 2014
474
PCR for the diagnosis of abdominal angiostrongyliasis in formalin-fixed paraffin-embedded human tissue. 61
24705328 2014
475
Strongyloidiasis and diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus. 61
25024706 2014
476
Travel-acquired infections and illnesses in Canadians: surveillance report from CanTravNet surveillance data, 2009-2011. 61
25009682 2014
477
Imported strongyloidiasis in Spain. 61
24211226 2014
478
Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population. 61
24454973 2014
479
Association between footwear use and neglected tropical diseases: a systematic review and meta-analysis. 61
25393620 2014
480
Bacteriophage-fused peptides for serodiagnosis of human strongyloidiasis. 61
24874206 2014
481
Autochthonous strongyloidiasis, Bordeaux area, South-Western France. 61
23433632 2014
482
Whats new in global infectious diseases? Strongyloidiasis and syndrome of inappropriate antidiuretic hormone secretion (SIADH). 61
24741222 2014
483
Strongyloidiasis: the cause of multiple gastrointestinal ulcers in an immunocompetent individual. 61
24648845 2014
484
Images of the month: A case of strongyloidiasis presenting as a colonic mass. 61
24402527 2014
485
Meningitis associated with strongyloidiasis in an area endemic for strongyloidiasis and human T-lymphotropic virus-1: a single-center experience in Japan between 1990 and 2010. 61
23761268 2013
486
Modified formalin-ether concentration technique for diagnosis of human strongyloidiasis. 61
24516283 2013
487
Pulmonary hydatidosis, strongyloidiasis and paragonimiasis in India. 61
24968568 2013
488
Strongyloidiasis complicating immunosuppression for pemphigus vulgaris. 61
23855642 2013
489
Physicochemical properties of the modeled structure of astacin metalloprotease moulting enzyme NAS-36 and mapping the druggable allosteric space of Heamonchus contortus, Brugia malayi and Ceanorhabditis elegans via molecular dynamics simulation. 61
24402824 2013
490
Determinants of reactivation of inapparent Strongyloides stercoralis infection in patients hospitalized for unrelated admitting diagnosis. 61
24081104 2013
491
Increased susceptibility to Strongyloides venezuelensis infection is related to the parasite load and absence of major histocompatibility complex (MHC) class II molecules. 61
24036323 2013
492
Notes from the field: Strongyloidiasis in a rural setting--Southeastern Kentucky, 2013. 61
24153316 2013
493
[Report of a case of strongyloidiasis with a coinfection by HTLV-1 and onychomycosis]. 61
24419034 2013
494
Co-morbid infections in Hansen's disease patients in the United States: considerations for treatment. 61
23980128 2013
495
Seroprevalence of Schistosomiasis and Strongyloides infection in HIV-infected patients from endemic areas attending a European infectious diseases clinic. 61
24010677 2013
496
Strongyloides stercoralis transmission by kidney transplantation in two recipients from a common donor. 61
23919410 2013
497
Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels. 61
23843560 2013
498
Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis. 61
23740923 2013
499
"Surprise" in the evolution of chronic membranoproliferative glomerulonephritis associated with severe strongyloidiasis under corticotherapy: "hygienic paradox"? 61
23826871 2013
500
Strongyloidiasis--a forerunner of adult T-cell lymphoma. 61
24851529 2013
501
Tropical diseases screening in immigrant patients with human immunodeficiency virus infection in Spain. 61
23509119 2013
502
Review of patients with Strongyloides stercoralis infestation in a tertiary teaching hospital, Kelantan. 61
23817397 2013
503
Laboratory detection of strongyloidiasis: IgG-, IgG4 - and IgE-ELISAs and cross-reactivity with lymphatic filariasis. 61
23448095 2013
504
Strongyloides stercoralis is a cause of abdominal pain, diarrhea and urticaria in rural Cambodia. 61
23688049 2013
505
The role of B-cells in immunity against adult Strongyloides venezuelensis. 61
23705584 2013
506
[Glucocorticoids and... infections, doping, surgery, sexuality]. 61
23415059 2013
507
Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997-2009, part 2: migrants resettled internationally and evaluated for specific health concerns. 61
23223602 2013
508
Cutaneous strongyloidiasis: direct finding of worms on skin potassium hydroxide examination. 61
23039845 2013
509
Transmission of Strongyloides stercoralis through transplantation of solid organs--Pennsylvania, 2012. 61
23575239 2013
510
Late diagnosis of central nervous system involvement associated with lethal dissemination of Strongyloides stercoralis in an advanced HIV patient from Nigeria. 61
23414737 2013
511
Strongyloidiasis: an emerging infectious disease in China. 61
23468357 2013
512
[High risk of strongyloïdes hyperinfection in a patient with sarcoidosis]. 61
23587590 2013
513
Parasitological and molecular diagnosis in experimental Strongyloides venezuelensis infection. 61
23563772 2013
514
Occurrence of strongyloidiasis among patients with HTLV-1/2 seen at the outpatient clinic of the Núcleo de Medicina Tropical, Belém, State of Pará, Brazil. 61
23740053 2013
515
Chasing Eosinophilia in Loeffler's Syndrome: A Case of Strongyloidiasis in Upstate New York. 61
23626967 2013
516
Strongyloides stercoralis in bronchoalveolar lavage specimen processed as Prussian Blue Stain. 61
21964988 2013
517
Mannose-binding lectin deficiency in a patient with multiple opportunistic infections, strongyloidiasis, and spindle cell tumor. 61
23352534 2013
518
Severe strongyloidiasis: a systematic review of case reports. 61
23394259 2013
519
Strongyloidiasis in a nonagenarian who previously worked in conservancy services. 61
23378359 2013
520
Fatal strongyloidiasis in an immunocompromised HTLV-I infected patient. 61
23108609 2013
521
Transcriptomic analysis of four developmental stages of Strongyloides venezuelensis. 61
23022620 2013
522
Ion-exchange protocol to obtain antigenic fractions with potential for serodiagnosis of strongyloidiasis. 61
22931968 2013
523
The laboratory diagnosis and follow up of strongyloidiasis: a systematic review. 61
23350004 2013
524
Non-communicable diseases, infection and survival in a retrospective cohort of Indigenous and non-Indigenous adults in central Australia. 61
23872293 2013
525
Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo. 61
23592987 2013
526
Strongyloides stercoralis infection in transplanted patients. 61
23826469 2013
527
[Strongyloides stercoralis in a patient with ankylosing spondylitis: case report]. 61
23955914 2013
528
Strongyloides stercoralis: highlighting an imported case of the neglected parasite. 61
23512515 2013
529
[Circumstances for diagnosis and treatment of intestinal parasitosis in France]. 61
23266344 2013
530
Pathology of CNS parasitic infections. 61
23829901 2013
531
Neglected tropical diseases of Oceania: review of their prevalence, distribution, and opportunities for control. 61
23383349 2013
532
Fatal strongyloides hyperinfection complicating a gram-negative sepsis after allogeneic stem cell transplantation: a case report and review of the literature. 61
23936693 2013
533
Strongyloides stercoralis infection complicating the central nervous system. 61
23829913 2013
534
Eosinophilia: A poor predictor of Strongyloides infection in refugees. 61
24421809 2013
535
Fulminant gastrointestinal hemorrhage due to Strongyloides stercoralis hyperinfection in an AIDS patient. 61
23563839 2013
536
Simultaneous Larva Migrans and Larva Currens Caused by Strongyloides stercoralis: A Case Report. 61
23476820 2013
537
A rare cause of severe recurrent abdominal pain. 61
23627200 2013
538
Strongyloides stercoralis infection presenting as an unusual cause of massive upper gastrointestinal bleeding in an immunosuppressed patient: a case report. 61
23443625 2013
539
E. coli Meningitis Presenting in a Patient with Disseminated Strongyloides stercoralis. 61
24324900 2013
540
A case of Strongyloides hyperinfection associated with tuberculosis. 61
25705401 2013
541
Detrimental effect of water submersion of stools on development of Strongyloides stercoralis. 61
24358173 2013
542
Identification of a bacteria-like ferrochelatase in Strongyloides venezuelensis, an animal parasitic nematode. 61
23516484 2013
543
Expatriates ill after travel: results from the Geosentinel Surveillance Network. 61
23273048 2012
544
Strongyloidiasis in a high risk community of Dhaka, Bangladesh. 61
23084030 2012
545
A fatal case of strongyloidiasis stercoralis superinfection in an immunocompromized patient. 61
23469642 2012
546
Marked eosinophilia due to intestinal strongyloidiasis in an immunocompetent patient. 61
23292062 2012
547
Strongyloidiasis presenting as larva currens 38 years after presumed exposure. 61
23149200 2012
548
[A case of steroid-induced hyperinfective strongyloidiasis with bacterial meningitis]. 61
23172283 2012
549
A novel approach based on antigen, antibody and immune complex detection in bronchoalveolar lavage fluid samples from rats experimentally infected with Strongyloides venezuelensis. 61
22897871 2012
550
Hyperinfection with Strongyloides stercoralis. 61
23203176 2012
551
Fatal disseminated strongyloidiasis after kidney transplantation. 61
23152354 2012
552
Strongyloides stercoralis disseminated infection and schistosomiasis in an AIDS patient. 61
31528586 2012
553
Spectrum of malabsorption syndrome among adults & factors differentiating celiac disease & tropical malabsorption. 61
23041739 2012
554
Production and evaluation of Toxoplasma gondii recombinant GRA7 for serodiagnosis of human infections. 61
22949752 2012
555
Symptomatic chronic strongyloidiasis in children following treatment for solid organ malignancies: case reports and literature review. 61
23018511 2012
556
Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin. 61
22975175 2012
557
Seroepidemiology of Strongyloides stercoralis in Dhaka, Bangladesh. 61
22813776 2012
558
Dexamethasone reduces bronchial wall remodeling during pulmonary migration of Strongyloides venezuelensis larvae in rats. 61
22808527 2012
559
Prevalence of Strongyloides stercoralis in an urban US AIDS cohort. 61
23265425 2012
560
Endoscopic and imaging findings in protein-losing enteropathy. 61
22138845 2012
561
Strongyloides stercoralis infection: a health issue regarding indigenous people in Taiwan. 61
22647849 2012
562
Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. 61
22691685 2012
563
Strongyloidiasis: a diagnosis more common than we think. 61
22555259 2012
564
Callithrix penicillata as a nonhuman primate model for strongyloidiasis. 61
22388422 2012
565
[High prevalence of strongyloidiasis among immigrants]. 61
23387007 2012
566
Hyperinfection of Strongyloides stercoralis in an immunocompetent patient. 61
23767024 2012
567
Bilateral parotid abscesses as the initial presentation of strongyloidiasis in the immunocompetent host. 61
21384459 2012
568
Imported strongyloidiasis: epidemiology, presentations, and treatment. 61
22322601 2012
569
Incidence rate and causes of infection in Thai systemic sclerosis patients. 61
22709489 2012
570
HTLV infection and strongyloidal hyperinfection syndrome. 61
23409425 2012
571
Use of larval, parasitic female and egg antigens from Strongyloides venezuelensis to detect parasite-specific IgG and immune complexes in immunodiagnosis of human strongyloidiasis. 61
22309625 2012
572
Ivermectin in human medicine, an overview of the current status of its clinical applications. 61
22039800 2012
573
Rare Case of Strongyloides stercoralis Hyperinfection in a Greek Patient with Chronic Eosinophilia. 61
22708034 2012
574
Strongyloides, dengue fever, and tuberculosis conversions in New Zealand police deploying overseas. 61
22530825 2012
575
A series on intestinal strongyloidiasis in immunocompetent and immunocompromised hosts. 61
23025061 2012
576
[Preparation of a prototype of the anthelmintic mitranox (MCT-31) and evaluation of its therapeutic efficacy in sheep moniesiosis and strongyloidiasis]. 61
22774511 2012
577
[Persistent Eosinophilia--differential diagnosis and work-up]. 61
22454311 2012
578
Antigen, antibody and immune complex detection in serum samples from rats experimentally infected with Strongyloides venezuelensis. 61
22306281 2012
579
Characterization of a secreted macrophage migration inhibitory factor homologue of the parasitic nematode Strongyloides acting at the parasite-host cell interface. 61
22037391 2012
580
Radiological appearance of small bowel in severe strongyloidiasis. 61
22370850 2012
581
Prevalence of Strongyloides stercoralis and other intestinal parasitic infections among mentally retarded residents in central institution of southern Iran. 61
23569874 2012
582
Strongyloidiasis: an emerging infectious disease that simulates allergic diseases. 61
22812198 2012
583
Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy. 61
22924046 2012
584
Gastric strongyloidiasis as multiple small gastric nodules. 61
23569473 2012
585
Republished research: Helminths: an unrecognised disease burden prevalent among migrants in the gastroenterology clinic. 61
22187490 2012
586
Strongyloides hyperinfection syndrome complications: a case report and review of the literature. 61
25134190 2012
587
Parasitic disease screening among HIV patients from endemic countries in a Toronto clinic. 61
23450241 2012
588
The transcriptome analysis of Strongyloides stercoralis L3i larvae reveals targets for intervention in a neglected disease. 61
22389732 2012
589
Vaccination with Strongyloides ratti heat shock protein 60 increases susceptibility to challenge infection by induction of Th1 response. 61
22172506 2012
590
Neglected tropical diseases: diagnosis, clinical management, treatment and control. 61
23180107 2012
591
Strongyloides stercoralis age-1: a potential regulator of infective larval development in a parasitic nematode. 61
22701676 2012
592
Survival in a case of diffuse alveolar hemorrhage due to Strongyloides stercoralis hyperinfection. 61
26029582 2012
593
Possible Strongyloides stercoralis infection diagnosed by videocapsule endoscopy in an immunocompetent patient with devastating diarrhea. 61
24713813 2012
594
Specific IgG and IgA to larvae, parthenogenetic females, and eggs of Strongyloides venezuelensis in the immunodiagnosis of human strongyloidiasis. 61
22015324 2012
595
Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges. 61
22310820 2011
596
Acute Lymphoblastic Leukemia with Eosinophilia and Strongyloides stercoralis Hyperinfection. 61
23056848 2011
597
Disseminated strongyloidiasis in a immunocompromised host. 61
22253157 2011
598
Innate and adaptive immunity to the nematode Strongyloides stercoralis in a mouse model. 61
22101674 2011
599
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009. 61
22325821 2011
600
Efficacy of parasitological methods for the diagnosis of Strongyloides stercoralis and hookworm in faecal specimens. 61
21896267 2011
601
Immunization with the recombinant antigen Ss-IR induces protective immunity to infection with Strongyloides stercoralis in mice. 61
21856350 2011
602
Epidemiological aspects of strongyloidiasis in Brazil. 61
21810305 2011
603
IgG avidity in differential serodiagnosis of human strongyloidiasis active infection. 61
21699917 2011
604
A multicenter evaluation of a new antibody test kit for lymphatic filariasis employing recombinant Brugia malayi antigen Bm-14. 61
20430004 2011
605
Prevalence and epidemiology of intestinal parasitism, as revealed by three distinct techniques in an endemic area in the Brazilian Amazon. 61
22117850 2011
606
Field survey for strongyloidiasis in eastern Uganda with observations on efficacy of preventive chemotherapy and co-occurrence of soil-transmitted helminthiasis/intestinal schistosomiasis. 61
20961473 2011
607
Impact of global health residency training on medical knowledge of immigrant health. 61
21896795 2011
608
[Combined infection with HTLV-1 and Strongyloides stercoralis]. 61
21800110 2011
609
Strongyloidiasis presenting as duodenal obstruction in a patient infected with human T-cell lymphotropic virus type 1. 61
21704987 2011
610
Diagnosis, clinical features, and self-reported morbidity of Strongyloides stercoralis and hookworm infection in a Co-endemic setting. 61
21886853 2011
611
Sytemic strongyloidiasis and primary aspergillosis of digestive tract in a patient with T-cell acute lymphoblastic leukemia. 61
21440299 2011
612
Chronic diarrhea and malabsorption due to hypogammaglobulinemia: a report on twelve patients. 61
21785992 2011
613
Gastrointestinal strongyloidiasis in immunocompromised patients: a case report. 61
21979285 2011
614
Concurrent infection of candidiasis and strongyloidiasis in an endoscopic biopsy in an immunocompetent host. 61
21934251 2011
615
Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis. 61
21814588 2011
616
Comment about nephrotic syndrome in association with strongyloidiasis. 61
21468622 2011
617
Strongyloidiasis presenting as eosinophilic ascites. 61
21871171 2011
618
[Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients]. 61
21879146 2011
619
Molecular Diagnosis of Strongyloides stercoralis Infection by PCR Detection of Specific DNA in Human Stool Samples. 61
22347284 2011
620
[Chronic Strongyloides stercoralis infection. Larva currens as skin manifestation]. 61
20963378 2011
621
Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patient. 61
21675505 2011
622
Strongyloidiasis in man 75 years after initial exposure. 61
21529417 2011
623
Donor-derived Strongyloides stercoralis infections in renal transplant recipients. 61
21358367 2011
624
Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. 61
21572981 2011
625
Usefulness of concanavalin-A non-binding fraction of Strongyloides venezuelensis larvae to detect IgG and IgA in human strongyloidiasis. 61
21513846 2011
626
Disseminated paracoccidioidomycosis (simulating metastatic lung cancer) and Strongyloides stercoralis hyperinfestation in a steroid-treated patient. 61
21430109 2011
627
Pulmonary strongyloidiasis associated CD3+ large granular lymphocytosis. 61
21572700 2011
628
Travel-related schistosomiasis, strongyloidiasis, filariasis, and toxocariasis: the risk of infection and the diagnostic relevance of blood eosinophilia. 61
21466667 2011
629
High prevalence of persistent parasitic infections in foreign-born, HIV-infected persons in the United States. 61
21532747 2011
630
Helminths: an unrecognised disease burden prevalent among migrants in the gastroenterology clinic. 61
28839594 2011
631
Risk factors for acquiring Strongyloides stercoralis infection among patients attending a tertiary hospital in south India. 61
21654109 2011
632
[Preparation of a prototype of the anthelmintic nadinate (MCT-02) and evaluation of its therapeutic efficacy in sheep moniesiosis and strongyloidiasis]. 61
21797067 2011
633
Novel real-time PCR for the universal detection of Strongyloides species. 61
21163829 2011
634
Fatal cutaneous Strongyloidiasis as a side effect of Pemphigus foliaceus treatment with mycophenolate mofetil. 61
21455554 2011
635
Strongyloidiasis: a multifaceted disease. 61
21528049 2011
636
Acute strongyloidiasis: a rarity. Chronic strongyloidiasis: a time bomb! 61
21366788 2011
637
Acute strongyloidiasis in Italian tourists returning from Southeast Asia. 61
21366799 2011
638
Update on strongyloidiasis in the immunocompromised host. 61
21308453 2011
639
Migratory route of Strongyloides venezuelensis in Lewis rats: comparison of histological analyses and PCR. 61
20801116 2011
640
Periumbilical parasitic thumbprint purpura: strongyloides hyperinfection syndrome acquired from a cadaveric renal transplant. 61
20525017 2011
641
A coproantigen diagnostic test for Strongyloides infection. 61
21347447 2011
642
An autopsy case of disseminated strongyloidiasis combined with cytomegalovirus infection. 61
21519131 2011
643
Strongyloidiasis in Assam, India: A community-based study. 61
23508997 2011
644
Colonoscopic findings and pathologic characteristics of Strongyloides colitis: a case series. 61
21266818 2011
645
Epidemiological and clinical picture of parasitic infections in the group of children and adolescents from north-east region of Poland. 61
22165741 2011
646
Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients. 61
21412582 2011
647
Gastric perforation caused by Strongyloides stercoralis: a case report. 61
21341143 2011
648
Strongyloides duodenitis: case report and review of literature. 61
21329250 2011
649
Strongyloides stercoralis hyperinfection in a post-renal transplant patient. 61
22235169 2011
650
Prompt diagnosis and treatment of strongyloidiasis in a renal transplant patient. 61
21119560 2011
651
[Clinical microbiology laboratory and imported parasitic diseases]. 61
20932605 2010
652
Strongyloidiasis: prevalence, risk factors, clinical and laboratory features among diarrhea patients in Ibadan Nigeria. 61
21735994 2010
653
Two donor-related infections in a heart transplant recipient: one common, the other a tropical surprise. 61
20888254 2010
654
The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells. 61
20644115 2010
655
Bacteremia caused by Aeromonas species [corrected] complex in the Caribbean Islands of Martinique and Guadeloupe. 61
21036850 2010
656
Albendazole stimulates the excretion of strongyloides stercoralis Larvae in stool specimens and enhances sensitivity for diagnosis of strongyloidiasis. 61
20844212 2010
657
Detergent fraction of heterologous antigen to detect IgA and IgG in strongyloidiasis using saliva and serum paired samples. 61
20816697 2010
658
Non-oral treatment with ivermectin for disseminated strongyloidiasis. 61
20889884 2010
659
Pulmonary strongyloidiasis: time to wake up. 61
21510123 2010
660
Diagnostic yield of double-balloon enteroscopy with intestinal juice analysis for intestinal strongyloidiasis. 61
21175501 2010
661
Strongyloides stercoralis: there but not seen. 61
20733481 2010
662
Fatal Strongyloides stercoralis hyper-infection in a patient with multiple myeloma. 61
21221486 2010
663
Strongyloides stercoralis infection in an HIV positive patient--a case report from RIMS, Imphal, Manipur. 61
22471190 2010
664
Proteomic analysis of Strongyloides stercoralis L3 larvae. 61
20388238 2010
665
Molecular identification of the causative agent of human strongyloidiasis acquired in Tanzania: dispersal and diversity of Strongyloides spp. and their hosts. 61
20621633 2010
666
Strongyloidiasis-related deaths in the United States, 1991-2006. 61
20682893 2010
667
Asymptomatic Strongyloides stercoralis hyperinfection in an alcoholic patient with intense anemia. 61
20738204 2010
668
Gastrointestinal helminthiasis presenting with acute diarrhoea and constipation: report of two cases with a second pathology. 61
20962736 2010
669
A case of gastric and duodenal strongyloidiasis. 61
21509240 2010
670
Minimal change nephrotic syndrome in a patient with strongyloidiasis. 61
20224878 2010
671
A new faecal antigen detection system for Strongyloides venezuelensis diagnosis in immunosuppressed rats. 61
20206167 2010
672
Duodenal obstruction - an unusual presentation of Strongyloides stercoralis enteritis: a case report. 61
20698992 2010
673
Diarrhea due to parasites particularly Cryptosporidium parvum in great Cairo, Egypt. 61
21246951 2010
674
Systemic lupus erythematosus and strongyloidiasis: a multifaceted connection. 61
20026523 2010
675
Eosinophilia and the seroprevalence of schistosomiasis and strongyloidiasis in newly arrived pediatric refugees: an examination of Centers for Disease Control and Prevention screening guidelines. 61
20400098 2010
676
Role of angiogenic factors in acute experimental Strongyloides venezuelensis infection. 61
20500674 2010
677
Disseminated strongyloidiasis caused by heart donor-to-host transmission presenting with purpura. 61
19886957 2010
678
Hydrophobic fractions from Strongyloides venezuelensis for use in the human immunodiagnosis of strongyloidiasis. 61
20356696 2010
679
Acute hemorrhage from small bowel diverticula harboring strongyloidiasis and schistosomiasis. 61
20506887 2010
680
Patterns and risk factors of helminthiasis and anemia in a rural and a peri-urban community in Zanzibar, in the context of helminth control programs. 61
20485491 2010
681
Evaluation of a rapid enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis. 61
20335415 2010
682
Staphylococcus warneri meningitis in a patient with Strongyloides stercoralis hyperinfection and lymphoma: first report of a case. 61
20602029 2010
683
Pancreatitis associated with Strongyloides stercoralis infection in a patient chronically treated with corticosteroids. 61
20444734 2010
684
High prevalence of Strongyloides stercoralis among school children in rural Côte d'Ivoire. 61
19916629 2010
685
Strongyloides stercoralis hyperinfection in a diabetic patient: case report. 61
20562820 2010
686
Uncomplicated strongyloidiasis in a liver transplant recipient on steroid-free immunosuppression. 61
20487417 2010
687
Cryptosporidium and Strongyloides stercoralis infections among people with and without HIV infection and efficiency of diagnostic methods for Strongyloides in Yirgalem Hospital, southern Ethiopia. 61
20359359 2010
688
An enzyme-linked immunosorbent assay as screening tool for human intestinal capillariasis. 61
20578511 2010
689
Strongyloides stercoralis and the immune response. 61
19892034 2010
690
Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment. 61
20003112 2010
691
Faecal examination and PCR to detect Strongyloides venezuelensis in experimentally infected Lewis rats. 61
20209330 2010
692
The drugs we have and the drugs we need against major helminth infections. 61
20627144 2010
693
Factors affecting recovery of Strongyloides stercoralis larvae: an approach to a newly modified formalin-ether concentration technique for diagnosis of strongyloidiasis. 61
19923489 2010
694
Gastrointestinal manifestations in severe strongyloidiasis: report of 3 cases and literature review. 61
20578478 2010
695
An unusual presentation of alveolar hemorrhage. 61
19756329 2009
696
Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view. 61
19892301 2009
697
Strongyloides stercoralis in a bronchial washing specimen processed as conventional and Thin-Prep smears: report of a case and a review of the literature. 61
19530103 2009
698
ELISA-based coproantigen in human strongyloidiaisis: a diagnostic method correlating with worm burden. 61
20120743 2009
699
Screening practices for infectious diseases among Burmese refugees in Australia. 61
19891864 2009
700
Strongyloidiasis in transplant patients. 61
19807271 2009
701
Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipient. 61
19843038 2009
702
Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases. 61
19501008 2009
703
Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. 61
19762378 2009
704
Strongyloidiasis--the most neglected of the neglected tropical diseases? 61
19328508 2009
705
Disseminated strongyloidiasis in immunocompromised patients--report of three cases. 61